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Summary 
Growing interest in the research community has been shown in clinical neuroscience to 
assess neurotransmitter profiling both in healthy and diseased subjects. A large body 
of research in this field focuses on schizophrenia to characterise its glutamatergic level 
according to the most recent hypothesis of NMDA (N-Methyl-D-aspartic acid) receptors 
hypofunction. 
Magnetic Resonance Spectroscopy (MRS) is able to detect some of the most com-
mon neurotransmitters but a number of issues, such as low signal to noise ratio (SNR), 
spectra overlapping and line broadening prevents MRS from being clinically relevant for 
neuropsychiatry. 
Four important aims were considered relevant for this work. 
Firstly, we aimed to compare the reliability of conventional and timing-optimized 
sequences for the detection and measurement of most of the visible metabolites and, in 
particular, for glutamate (Glu), glutamine (GIn) and gamma-aminobutyric acid (GABA) 
to assess the best available sequence for a study in schizophrenia. 
VII 
Secondly, we also intended to investigate whether glutamatergic activity might predict 
the oscillatory activity and how this link might survive or not in schizophrenia. 
Thirdly, we wanted to study whether the well known animal model of schizophrenia, 
the rearing in isolation model, exacerbates the effect of ketamine and determines more 
profound changes on neurotransmitter profile in rats. 
Fourthly, a further goal focuses on the improved data acquisition and on the da-
ta processing to reliably resolve GABA and to be able to quantify a wider range of 
metabolites. 
To address those points five studies were performed. 
The first work (Chapter 3) describes a study of reproducibility on sequences which 
have been reported in the literature to be capable to detect Glu and GIn. The study was 
performed on 14 healthy subjects by scanning them twice and repositioning between the 
two scans. The absolute percentage difference was then computed to assess the accuracy 
per sequence and metabolite. A good compromise was found in PRESS sequence (TE=80 
ms) which was exploited subsequently for the following study on schizophrenic patients 
(Chapter 4). Twenty-seven early stage schizophrenic patients and twenty-three aged-
matched controls were recruited to undergo a protocol including, in two separate sessions, 
MRS and electroencephalography (EEG). Anterior Cingulate Cortex Glu was found to 
predict the induced theta activity in healthy controls but not in patients. Furthermore, 
the NAA values have also been found to be reduced in schizophrenia and linked to NlOO, 
an Event Related Potential (ERP) which is well known to be decreased in schizophrenia. 
Following on from the findings of the study on the early stage of schizophrenia, 
VIII 
further investigations were undertaken to study the psychotic state occurring in the 
disease via a functional MRS, where 25mg/kg of ketamine (NMDA antagonist) injection 
was administered to two groups of rats. The two groups were group-housed and reared 
in isolation. This work was able to show increase of prefrontal GIn levels in both groups 
but showed a selective GABA decrease only in isolated rats. It would have been very 
interesting to be able to detect GABA changes in the study at 3T but the used protocol 
did not allow its accurate quantification. 
Simulations and reliability tests (Chapter 6)were then utilized to optimize a stan-
dard sequence to obtain an accurate and reliable GABA concentration. The optimized 
sequence reproduces the quantification with 12% of accuracy. 
The preliminary results of the last study (Chapter 7) give an evidence of the potential 
of combined use of Monte Carlo, Levenberg-Marquardt and NNLS methods embedded 
in a novel fitting approach for two-dimensional spectra. 
The three appendices at the end of this work illustrate the details of some of the 
algorithms and softwares used throughout the studies. 
Part I 
Introduction to NMR and MRS 
1 
N,4clear Magnetic ~ e s o n C i n c e e
Nuclear Magnetic Resonance (NMR) is one of the methods used to investigate matter 
and it has been extensively described in numerous texts (Levitt [2001]). This chapter 
outlines the main principles of the NMR theory. 
1.1 NMR basic principles 
The atom contains electrons, negatively charged, and a nucleus that includes protons, 
positively charged and neutrons that have no charge. The nucleus has three fundamental 
properties: mass, electronic charge and spin. The spinning motion of nuclei in the mat-
ter is the basis of NMR principles. In particular, nuclei with spin angular momentum 
can interact with a magnetic field: the resonant angular frequency, also called Larmor 
frequency WL, is given by the following equation 
(1.1) 
NMR basic principles 3 
Isotope Nuclear Spin 27r/, (MHz/T) Natural Abundance (%) 
1H 1/2 267.52 99.9 
13C 1/2 67.28 1.1 
14N 1 19.34 99.6 
23Na 3/2 70.81 100 
19F 1/2 251.81 100 
31P 1/2 108.39 100 
Table 1.1: Properties of common nuclei used for magnetic resonance (Levitt [2001]). 
where/, is the gyromagnetic ratio, which is a unique constant for each nuclear isotope. 
The numerical values for the gyromagnetic ratios of the most common atoms used in 
NMR are given in table 1.1 together with other properties. 
A nucleus is called MR active when either the atomic number or mass number is 
odd. In this case, the nucleus can align to an external magnetic field because of its 
magnetic moment. This alignment is specific for each nucleus, thus giving a specific 
NMR sensitivity. The gyromagnetic ratio determines the proportionality between the 
spin angular momentum and the magnetic moment according to the following 
(1.2) 
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where fl and S are quantum mechanical operators. The magnetic energy Emag of the 
interactions between the particle and an external magnetic field is the scalar product of 
the particle's magnetic moment fl and the external magnetic field B 
(1.3) Emag = -fl· B 
thus meaning that the lower state energy is for parallel vectors. Hydrogen nuclei are 
the most common and abundant in biological matter and since no other nuclei were used 
for this thesis, 1H NMR is the main subject of the following sections. 
1.2 Spin and energy levels 
The hydrogen atom consists of an electron and a single proton. As all the nuclei with 
unpaired nucleons, it has a net nuclear angular momentum, p, that is quantised and is 
given by 
(1.4) p = ny'J(I + 1) 
where n is the Planck constant (6.262 x 1034 J s). The z-component of the angular 
momentum are given by 
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Figure 1.1: Energy level diagram of the hydrogen nucleus (spin 1/2) in a magnetic field. 
Transitions between the two states are possible when a radiofrequency wave with energy 
equal to the energy level splitting tl. E is applied. 
(1.5) pz = nmz 
where m z can have values -I, -1+ 1, -1+2, ... , 1-2, I-I, 1. For the case of hydrogen m z can 
be 1/2 and -1/2 since its spin quantum number is 1/2. These values determine the number 
of degenerate energy states that the system has in the absence of an external magnetic 
field. The separation between the two allowed energy states, given by ~ E = n ' Y YBz , is 
. known as Zeeman splitting. Spectroscopy involves the application of an electromagnetic 
field to introduce transitions between the two spin states, figure 1.1. 
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1.3 Bulk magnetisation 
Real systems consist of many individual spins and the observed macroscopic quantities 
reflect the average response from the sample. The bulk magnetisation is the superposition 
of the multiple magnetic moments in a sample exposed to an external magnetic field. 
Boltzmann statistics is used when describing the population of the states for an ensemble 
of noninteracting spins. In particular, it gives the distribution of the spins in the two 
energy states described earlier as the following 
(1.6) Nf3 _ AE _ ""YBo - = e kT = e kT 
NOt 
where k is the Boltzmann constant (1.38 x 10-23 J/K) and T is the temperature. Since 
the Zeeman energy is small compared to thermal energy at normal room temperature i.e. 
kBT» n"(Bz, the difference in population between the two states can be approximated 
to: 
(1.7) 
where N is the total number of spins in the system. Equation 1. 7 clearly shows the 
difference which for a macroscopic sample containing one million nuclear spins at 37°C 
and in magnetic fields of 7 T and of 3T is only 2.3 spins (corresponding to 0.0023%) and 
1 spin (corresponding to 0.00098%) respectively. 
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This means that the z-component of the magnetisation, m z , is defined by the thermal 
equilibrium of the system and it depends on the temperature and on the strength of the 
external magnetic field Bo. 
Since decreasing the temperature of the sample is not feasible in clinical applications, 
increasing the magnetic field strength seems to be the best option to increase the NMR 
signal. 
1.4 Bloch equations and Relaxation 
The behaviour of the expectation value of the bulk magnetization M can be described 
in terms of classical equations, and in particular: 
(1.8) dM(t) = 'Y(M(t) x B(t)) 
dt 
Since no net x and y component of M(t) is present at thermal equilibrium, no NMR 
signal can be detected. From equation 1.8 it follows that M z can be perturbed by a second 
magnetic field perpendicular to Mz . This field is rotating at the Larmor frequency in the 
Radiofrequency (RF) range of the electromagnetic spectrum, it is often referred to as a 
RF magnetic field. The magnetic component of a RF field that is linearly polarized along 
the x axis in the laboratory frame can be written as: 
(1.9) 
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The equation 1.9 in presence of this new field BI{t) can be written as: 
(1.1O) dMx -yMyBo = dt 
(1.11) dMy -y{MzBlx - MxBo) dt 
(1.12) dMz -yMyBlx -- = dt 
From these equations of motion it can again be found that application of an electro-
magnetic pulse, applied at the Larmor frequency, will cause the magnetization (originally 
aligned along the z-axis) to be tipped into the transverse plane through an angle given 
by () = -yBIT (where T is the duration of the pulse). 
After the magnetization is tipped into the transversal plane an important phenomenon 
occurs, the relaxation. That is the process of return to thermal equilibrium after a per-
turbation. Components of the magnetization M (Le.Mx,My and Mz) return to thermal 
equilibrium in an exponential manner. The components perpendicular (i.e.Mx and My) 
and parallel (Le.Mz ) to BO relax with different time constants. 
1.4.1 Longitudinal Tl relaxation 
Relaxation in the z-axis is called longitudinal, spin-lattice or TI relaxation and it is 
described by the Bloch equation 
(1.13) 
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where Mo is the longitudinal magnetisation at equilibrium and Tl is the longitudinal 
relaxation time. Tl is specific for different kinds of matter and depends on the magnetic 
field strength: the higher the magnetic field the longer the T1. It is possible to calculate the 
Bloch equation for two particular pulses: a 180° inversion pulse and a 90° readout pulse. 
In the first case, the magnetisation is completely inverted which means that M z (O)=-Al0 . 
One can then write the equation as 
(1.14) 
For the case of a 90° readout pulse the equation becomes 
(1.15) 
which is usually called saturation recovery curve. The two curve are represented in 
figure 1.2 
1.4.2 Transverse T2 relaxation 
The previous section presented the relaxation due to the dipole-dipole interactions at 
the Larmor frequency. Another relaxation phenomenon, due to the short range spin-spin 
interactions, is called transverse or T2 relaxation. As for T1 , the T2 constant also depends 
on the magnetic field strength. In analogy with the previous case it is possible to write 
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Figure 1.2: Illustration of the function of time for inversion recovery (red solid line) and 
saturation recovery (blue solid line). 
the Bloch equation describing the behaviour of the magnetisation in the transverse plane 
as follows 
(1.16) 
where T2 is the transverse relaxation time. The n constant is always smaller than 
Tl and it tends to be shorter when the molecules where the spins are in are more rigid 
and less free, while in molecules as water it tends to be longer because they are more 
mobile. Following the application of the RF pulse, these dipole-dipole interactions cause 
an exchange of energy and a consequent loss of coherence of the transverse magnetisation. 
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The decay of the amplitude of the transverse magnetisation follows an exponential decay 
as described by the following equation 
(1.17) 
This signal decay is known as Free Induction Decay (FID) and it is a key concept 
when considering the signal "echoes". 
At this point it is important to consider that in real systems, the NMR signal decays 
faster than just described. This further decay is due to the Bo field inhomogeneities, which 
can be described by the constant T ~ . . The total relaxation time is then the following 
(1.18) 
where T2* results always shorter than T2. Figure 1.3 illustrates the FID decay con-
sidering the T2 * effect. 
In general, including the relaxation effect into the equation 1.9 the Bloch equation 
can be deducted: 
(1.19) dM(t) = ,(M(t) x B(t)) _ (Mx) x _ (AfY) Y _ ((Mo - Mz)) z dt T2 T2 Tl 
My 
\ 
\ 
"\ 
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Figure 1.3: Illustration of the FID decay (blue line) over time showing the T2* effect (red 
line). 
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Magnetic Resonance Spectroscopy (MRS) has been widely studied and described since its 
discovery. This chapter gives an overview of the basic principles and the methods which 
are extensively reported elsewhere (R. A. De Graaf [2007], Bernstein et al. [2004]). 
2.1 Quantum description of NMR 
The energies and the wavefunctions of atoms and molecules can be obtained by solving 
the following Schroedinger equation 
(2.1) iN! = E'l! 
Nuclear spin states can be described with an analogous expression but it and 'l! are 
very different. Instead of differential operators yr2 and position operator functions, the 
hamiltonian 1l contains spin angular momentum terms nIx, n±.y, nIz. It may be shown 
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that the three angular momentum operators obey the commutation relationship, thus 
having 
(2.2) 
and each of them also commutes with the operator 
(2.3) 
In order to describe the quantum state of a system it is useful to introduce the 
ket notation in the Hilbert space, which is considered discrete and finite-dimensional 
for convenience. Every ket is associated to a possible state of the system and has a 
corresponding bra In) and they obey tho the following orthonormalization condition 
(2.4) (m I n) = 8mn 
It possible to choose as a state ket, one set of normal autofunctions of T and iz 
which we may indicate as II, m) and we can define the shift operators i+ and I_ as 
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(2.5) 
(2.6) 
The shift operators obey the cyclic commutation relationship 2.2, therefore we can 
describe the result of applying such operators to the set of autofunctions II, m) as 
(2.7) 
(2.8) Iz\l, m) = mIl, m), 
(2.9) i+II, m) = [1(1 + 1) - m(m + 1)j1/2II, m + I), 
(2.10) :L\l,m) = (I(I + 1) - m(m -1)p/2\I,m -1), 
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2.1.1 Zeeman hamiltonian 
The spin hamiltonian il for the interaction of each spin with the static magnetic field 
Bo is given by 
(2.11) 
N 
il = - L.: 'YjliBo . I j 
j=l 
Considering only the longitudinal contribution of the static magnetic field and n=l, 
equation 2.11 can be simplified as 
(2.12) 
N 
il = - Lwojizj with WOj = "(jBo 
j=l 
This is called nuclear Zeeman interaction. The result of applying the operator il on 
II, m) gives the sum of the energies of the spins as 
N 
(2.13) E = L::WOj 
j=l 
2.1.2 Chemical Shift 
The resonance frequency of a nucleus doesn't depend only on the gyromagnetic ratio 
"( and the external magnetic field Bo but also on its chemical environment. This phe-
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nomenon, called chemical shift, is caused by the shielding of the electrons that surround 
the nucleus: in fact, electrons in the molecules cause small changes in the magnetic field 
experienced by the nuclei, so nuclei in different chemical environments experience slightly 
different fields. In particular, the electrons reduce the magnetic field that is sensed by a 
nucleus because they orbit the nuclei, so to have an associated magnetic moment that 
opposes the applied Bo. In order to describe the chemical shift phenomenon it is possible 
to write the equation for the effective magnetic field at the nucleus as 
(2.14) B(O") = Bo(1 - 0") 
where 0" is the chemical shift shielding constant for the nucleus which is a dimension-
less number usually expressed in parts per million (ppm). Under fully relaxed conditions 
the ratios of the signals at different frequencies in the spectrum indicates the relative 
number of protons associated with that particular environment. 
The Zeeman hamiltonian including the chemical shift for each nuclei is then given 
by: 
N 
(2.15) i£((j) = - Lwoj(O"j)Izj with WOj(O"j) = 'YjB(O"j) 
j=l 
The chemical shift of a nucleus is usually measured relative to the shift of a 'reference' 
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peak in ppm calculated by: 
(2.16) 8(ppm) = (I/reJ) - (1/) X 106 
I/trans 
In this equation I/reJ is the frequency of the reference peak, 1/ is the measured frequency 
and I/trans is the transmitter frequency of the spectrometer. The reference compound 
should be chemically inert and its chemical shift should be independent of external 
variables such as temperature or ionic strength. It should also have a strong singlet 
resonance peak separated from the others. Tetramethylsilane (TMS) is usually used as 
reference compound for 1H and 13C NMR. However, TMS is not present in in vivo 
systems, therefore it cannot be used as an internal reference. For in vivo applications, 
internal references are the methyl resonance of N-acetyl aspartate (2.01 ppm) for 1H 
MRS of the brain and the phosphocreatine resonance (0.00 ppm) for 31P MRS of brain 
and muscle. 
2.1.3 Dipole-Dipole Coupling 
Dipole-dipole interaction involves the interaction between two spins, each of which gen-
erates a magnetic field with direction dependent on the orientation of the spin. Dipole-
dipole coupling is dependent on the direct interaction of the nuclear spins with each and 
can occur between different nuclear spins within a molecule, or between spins in adjacent 
molecules. For two nuclear spins (j and k), the hamiltonian describing this interaction is 
given by: 
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(2.17) 
where bjk is the dipole-dipole coupling constant given by 
(2.18) 
ejk is a unit vector in the direction along a line joining the two nuclei centres and rjk 
is the distance between the two spins. 
Even though dipolar interactions are the main mechanism for relaxation in liquids, 
the dipole-dipole coupling term averages to zero over time because of the rapid molecular 
tumbling and therefore the dipole-dipole terms are not included in the hamiltonian. 
2.1.4 J-Coupling 
J-coupling is an NMR phenomenon in which protons in adjacent groups of the same 
molecule interact with one another and split the resonance frequency into doublet, triplet, 
quadruplet and so forth. This interaction between the nuclei in a molecule is via the 
bonding electrons. For an isotropic liquid we discriminate between the homonuclear or 
heteronuclear cases. 
The Hamiltonian for the homonuclear, i.e. nuclei of the same species, (e.g 1H _1 H) 
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case is given by: 
(2.19) 
where J(jk) the j-coupling tensor, a 3 x 3 real matrix. It depends on molecular orientation. 
In isotropic liquid it reduces to a number which is called scalar coupling. 
The value of J(jk) depends on the effect that the spin orientation has on the energy 
and is generally positive, in which case the energy is increased if the spins are parallel 
and decreased if they are anti-parallel. 
If we consider two nuclei (j and k) with a covalent bond (J(jk) > 0), there can be four 
different possible spin-orientations, with the most likely, i.e. with lower energy, being the 
one in which the spins are anti-parallel. The transitions from parallel to anti-parallel and 
from anti-parallel to parallel have slightly different energies, therefore the resonance peak 
is split into two peaks of equal intensity as each transition has the same probability to 
happen. The splitting of the peak due to spin k is also split into two equal components 
in the same way. 
2.2 Radiofrequency Pulses and Gradients 
2.2.1 RF Pulses 
As we have already stated, in order to observe nuclear magnetization, the precessional 
motion needs to be detected. However, at thermal equilibrium, the spins have no phase 
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coherence in the transverse plane and the net longitudinal magnetization is a static 
vector. Nuclear magnetization can only be observed by rotating the net longitudinal 
magnetization towards or onto the transverse plane. This can be accomplished by a 
second magnetic field in the transverse plane oscillating in the RF (MHz) range, the 
radiofrequency pulses: B1 (w). They are the primary tools used to perform the desired 
spin manipulations like excitation, inversion and refocusing. Short, intense, constant-
amplitude RF pulses (Le. square RF pulses) are often used to achieve uniform excitation 
of the spins across a given frequency range. However, many in vivo NMR experiments 
require more sophisticated RF pulses. 
Square RF Pulses 
When the amplitude of the RF pulse IrB11 » I ~ n l l (where ~ n = w w - wo, respectively 
the difference between the irradiating field B1 and the Larmor frequency), the effects 
off-resonance can be neglected and the nutation angle () is 
(2.20) 
where T is the pulse length. However, the off-resonance effects cannot be always ignored 
since it is possible that the spectra width is similar to the strength of RF field. In this 
situation the magnetization will not rotate about B 1, but about tilted effective field Be 
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(figure 2.1) the amplitude and tilting angle 'ljJ of which are given by 
(2.21) 
(2.22) ~ n n'ljJ = arctan( -B ) 
'Y 1 
The equation 2.20 should therefore, in the case of non-negligible off-resonance, be 
modified to: 
(2.23) 
As you can see in the figure 2.1, the rotation axis is Be. In this case, the actual 
rotation becomes more complex that a rotation about the BI? and it involves sequential 
rotations about different axis. Such rotations around arbitrary axis are easily described 
by rotations about the principal axis x', y', z'. The general procedure to determine the 
rotated magnetization is as follows: 
• Performing transformations which align rotation axis Be with one of coordinate 
axis (Le. x') (Ry('ljJ)) 
• Performing rotation about the new axis (Rx(f))) 
• Performing the rotation to bring back the axis (Rz( -¢)) 
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Figure 2.1: In general the magnetization precedes about the Be which is the vectorial 
sum of the two magnetic fields present during the spin excitation. 
Following these points we can describe the rotations like: 
(2.24) 
Besides the rotation matrix for RF pulse with a phase ¢> relative to the x' axis is obtained 
with an additional rotation about z' 
(2.25) R(O, t/J, ¢» = Rz(¢»R(O, t/J)Rz( -¢» 
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where the rotation matrices are 
1 o o 
Rx(a) = 0 cosa -sina 
o sina cos a 
cos f3 0 sin f3 
o 1 o 
- sin f3 0 cos 13 
cos, - sin, 0 
Rz (')') = sin, cos, 0 
o o 1 
and the product of the three matrices as 2.24 is given by 
cos21/; + cos 0 sin 21/; sin 1/; sin 0 sin 1/; cos 1/; (1 - cos 0) 
R(O,1/;) = 
- sin 1/; sin 0 cosO cos 1/; sin 0 
Considering the thermal equilibrium magnetization along the z' axis such that M(O) 
= Mo z' and calculating M(t) = R(O, 1/;) M(O) we can obtain the magnetization compo-
nents after the pulse: 
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(2.26) 
(2.27) 
(2.28) 
The figures 2.2(a), 2.2(b) and 2.3 show the effect of off-resonance frequencies on the 
magnetization profiles. In the case of 1800 pulse l\1z is inverted only for values of t10/",(B1 
approximately close to zero. 
0.8 
0.8 
I: o. 
• 0.2 
i 0 
Q. -0.2 
e 
'" -0.4 
-0.8 
-0.8 
' ~ ' : : - O O - 7 - 8 - - 8 7 - - ~ " - - ; - . 2 2- 0 ~ - : - 2 - ~ - 7 - - - - : - - - - - - - : ' 0 0
Aotr B, 
(a) Mx 
0.8 
0.8 
1° 0.0 
... 02 
j 0 
1 -02 
-0.0 
-0.8 
- O ' ~ O - 8 - 8 " - 2 2 0 2 
AOtr B, 
(b) My 
Figure 2.2: Off-resonance frequency dependence of the Mx and My components to different 
angles square RF pulses. 
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Figure 2.3: Off-resonance frequency dependence of the Mz component to different angles 
square RF pulses. 
Fourier transformation is commonly used in NMR to calculate the frequency profile 
of the RF pulses. For a squared pulse of length T, Mx and My can be calculated by 
Fourier transformation. In general we can simply calculate that by: 
(2_29) 
1
+00 1+00 rT B(Don) = -00 B(t) e - i ~ n t t dt = -00 B(H(t) - H(t - T)) e - i ~ n t t dt = Jo B e - i ~ n t t dt 
where H is the Heaviside step function to describe the rectangular function. 
The real and imaginary components will give the transverse magnetization profile for 
both the components: 
(2.30) At = At 1 - cos( Don . T) 
x 0 Don. T 
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(2.31) M = M sin(.6.0 . T) y 0.6.0· T 
From the comparison with the equations 2.26 and 2.27, it is evident that the Fourier 
Transformation does not reproduce exactly the frequency profile. The reason relies upon 
the linearity of the Fourier transformation: in fact, signal excitation on NMR is far away 
from being linear and that causes the observed discrepancies when the nutation angle is 
not small enough. 
In general, hard pulses are very infrequently used. Also, most of the times imple-
menting a hard pulse can be a problem because of poor fidelity with which RF amplifiers 
can reproduce the waveform discontinuities. However, they are conceptually important 
to approximate the computation of shaped pulses by segmenting the pulse in parts small 
enough such that the RF amplitude is considered constant. 
Selective Pulses: sinc pulses 
For many applications selective excitation is required. In fact the sine-like excitation 
profile of an hard pulse might significantly excite spins off-resonance. This leads to the 
concept of RF pulses which have a well-defined selective frequency profile and hence 
able to select a certain range of frequencies. From the Fourier transformation theory a 
rectangular shape profile in the frequency domain has a sinc function shape as Fourier 
transformation in the time domain. Sinc pulses have been widely used for selective exci-
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tation, saturation, and refocusing. Since this pulse would need infinite duration (due to 
the asymptotic decay of the sinc function), it is normally truncated at zero-crossings. In 
general a sinc pulse consists of several adjacent lobes of alternating polarity (see figure 
2.4). The central lobe has the highest amplitude and is also twice as wide as every other 
lobe. The amplitude of the lobes progressively decreases on either side of the central lobe, 
as their polarity alternates. In particular, a sine-shaped RF pulse of duration T is given 
by: 
(2.32) ! ~ ~A TO trt ' -NLTO ~ ~ t ~ ~ NRTO B 1{t) = 0, elsewhere 
where A is the peak RF amplitude occurring at t = 0, TO represents one-half the width of 
the central lobe (which is equal to the full width of each side lobe), and NL and NR are 
the number of zero-crossings in the sine pulse to the left and right of the central peak, 
respectively. If NL = NR, the sine pulse is symmetric. The bandwidth of the sinc pulse 
can be approximated by: 
(2.33) 1 ~ W ~ ~
TO 
Naturally, truncating the sinc pulse caused small oscillations in a 300 sinc pulse frequency 
profile. On the other hand, a non negligible deviation from the ideal behavior occurs for 
a 1800 pulse. However, adding more lobes can solve the wrinkle problem to the frequency 
profile but it may increase the pulse duration thus leading to prolong the minimum TE 
and TR in the sequences. 
(a) One-lobe 
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(b) Three-lobe 
~ - - ~ - - ~ - " - -
-2 , • , , I 
, 
(c) Seven-lobe 
Figure 2.4: Sinc pulse displayed for one-lobe, three-lobe and seven-lobe truncation. 
2.2.2 Gradients 
Magnetic field gradients are fundamental to MR imaging and spectroscopy because they 
are responsible for the spatial encoding of the NMR signal along the three orthogonal 
directions (x,y,z). Gradients are also used to minimize image artifacts and reduce the 
amount of unwanted signal. A magnetic field gradient is produced from a current flowing 
in loops of coils placed just inside the magnet bore. A gradient vector G can be expressed 
as follows: 
(2.34) 
where X, Y and z are the unit vectors of the coordinate system and Gx , Gy and Gz 
are the three orthogonal components of gradient vector G. Therefore, the gradient's 
magnetic field depends on both the distance from the centre of the magnet and the 
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gradient's strength. Equation 2.34 also shows that although gradients are orthogonal to 
each other, each gradient produces a magnetic field in the z direction given by 
(2.35) 
At the centre of the gradient set known as the "isocentre", where all three axes cross 
each other, the effect of any gradient diminishes. Gradient amplitudes are typically ex-
pressed in milliteslas per meter (mT /m) and depend on the amount of electric current 
flowing in the gradient windings as well as the gradient coil size. The direction of the 
gradient is determined by the sign of the electric current. Typical values for whole-body 
gradient systems are f'V 10-50 mT/m (80 mT/m for Philips platform in enhanced mode). 
Furthermore, slew rate is defined as the rate at which the gradient's amplitude changes 
between zero and its maximum required value and back down. The usual values on cur-
rently used 3T scanners are 150-200 mT /m/ms. A gradient lobe is defined as a single 
gradient pulse shape that starts and ends with zero amplitude. The three basic functions 
that the gradients perform (frequency encoding, phase encoding and slice selection) often 
require more than one gradient lobe. 
The area A of a gradient lobe when plotted versus time is typically determined by the 
spectroscopic parameters such as voxel size and pulse bandwidth. The shortest duration 
gradient lobe is normally used to minimize parameters such as TE and TM. Figure 2.5 
shows two common gradient lobe shapes, a triangle and a trapezoid. Gradient pulses in 
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Figure 2.5: Examples of two common gradient lobe shapes, a triangle (left) and a trape-
zoidal (right). The amplitude of the plateau of the trapezoid is h, the ramp of the trapezoid 
is r. 
conventional pulse sequences are generally designed to be trapezoidal in shape, consisting 
of sloping rise followed by fiat plateau and sloping fall. 
The plateau duration Tplateau can be calculated as 
(2.36) IAI Tplateau = h - r 
where h is the amplitude of the plateau of the trapezoid and r is the ramp time. 
Therefore the duration of the entire trapezoidal lobe is 
(2.37) T = Tplateau + 21' = I ~ I I + l' 
The triangle lobe shape is used when the desired gradient area is less hr because it 
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is the most time-efficient. 
In the case of adjacent lobes of the same polarity, some triangle and trapezoidal lobes 
can be combined, or bridged, to improve the time efficiency. 
There is a variety of gradient waveforms used to correct or prevent image artifacts: 
• Slice-selection gradient: slice-selection gradient is a gradient used to achieve the 
desired spatial localization. The slice-selection gradient (the name comes essentially 
from imaging) is typically a constant gradient that is played concurrently with 
the selective RF pulse (see figure 2.6). In the case that the RF pulse performs 
excitation, then a slice rephasing gradient lobe usually follows the slice-selection 
gradient. As already said, the selective RF pulse has sinc waveform and its RF 
bandwidth (expressed in hertz) gives the range of frequencies contained in the RF 
pulse. The slice-selection gradient translates the band of frequencies into the desired 
band of locations, corresponding to one of the slices defining the voxel. 
• Slice-refocusing or-rephasing gradients: an effect of phase dispersion of trans-
verse magnetization can be observed across the excited slice when a slice-selection 
gradient and a RF selective pulse are contemporarily played. The exact nature of 
the dispersion is determined by the shape of the RF excitation pulse. The trans-
verse magnetization, for instance, would be linearly phase modulated across the 
slice if a linear phase RF excitation pulse is used (figure 2.7). To overcome this 
problem, a slice-refocusing or rephasing lobe is associated with the slice-selection 
gradient of an excitation pulse. The lobe of this type of gradients has opposite po-
larity compared to the slice-selection gradient and is indeed used to compensate for 
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Figure 2.6: Slice selective gradient and RF selective pulse (sinc) concurrently played 
for slice selection. 
the phase dispersion deriving from the slice-selection gradient. This dramatically 
reduces the signal loss due to the phase dispersion in the voxel. Using the isodelayl 
of an excitation RF pulse function ~ t i B O O to calculate the optimal area of rephasing 
gradient lobe (see figure 2.8). The optimal area of the slice-refocusing gradient lobe 
is then: 
(2.38) hr A = 2" + h ~ t i B O O
where h represents the gradient amplitude and r indicates the ramp . 
• Crusher gradients: crusher gradients (figure 2.9) are used to eliminate the FIDs 
IThe isodelay of an RF excitation pulse is approximately equal to the time from the peak to the end 
of the RF excitation pulse. 
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Figure 2.7: After the selective RF pulse is played on one axis on the transversal 
plane, the transverse magnetization at different spatial locations will generally not 
lie exactly along its perpendicular axis in the rotating frame because of precession 
caused by the slice selection gradient. 
dt 
h 
t 
A 
Figure 2.8: Slice selective gradient followed by a rephasing gradient lobe with 
optimal area computed from the isodelay of the RF selective pulse. 
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that result from nonideal refocusing pulses by manipulating the phase of the signals. 
A crusher gradient consist of two lobes with the same polarity, one immediately 
before the refocusing pulse and the second one immediately after. 
Crusher gradients are extensively used in pulse sequences where at least one re-
focusing RF pulse is present. For example, in multiple spin-echo pulse sequences, 
stimulated echoes are crushed out by varying the amplitude of the crusher gradient 
throughout the echo train so that the acquired signal has a pure T2 exponential 
decay as a function of the TE . 
• Spoiler gradients: spoiler gradients (figure 2.10) are designed to eliminate spuri-
ous signal due to residual transverse magnet is at ion at the end of a pulse sequence. If 
not eliminated, this signal can lead to image artifacts. Therefore, spoiler gradients 
are usually applied at the end of a pulse sequence or at the end of a preparatory RF 
pulse. When a spoiler gradient is applied, the transverse magnetisation dephases 
along the direction of the gradient, leading to signal cancelation within a voxel. 
The longitudinal magnetisation is not influenced by the spoiler gradient and thus 
is preserved to give signal in subsequent data acquisition. 
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Figure 2.9: Examples of a crusher gradient pair at both sides of a refocusing pulse. 
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Figure 2.10: Examples of spoiler gradients, applied at the end of a pulse sequence (top) 
or after a preparatory RF pulse (bottom). 
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2.3 Single Volume Localization 
For in vivo MRS it is generally required to restrict signal detection to a well-defined re-
gion of interest (ROl). Nevertheless, spatial localization is also used to remove unwanted 
signals from outside the ROl, like extracranial lipids in MRS applications of the brain. 
Localization methods based on magnetic field gradients rely on the selection of a spa-
tially selective slice by the application of a frequency-selective RF pulse in presence of a 
magnetic field gradient. 
2.3.1 Point Resolved Spectroscopy (PRESS) 
Consider the PRESS sequence of figure 2.1l. PRESS consists of a 900 excitation pulse 
and two 1800 refocusing pulses. The first 1800 pulse is played at time TE1 /2 after the 
excitation pulse. A spin echo then is formed at time TEl' The second 1800 pulse refocuses 
this spin echo during a second delay TE2 , such that the final spin echo is formed at 
time TE = TEl + TE2 . The three RF pulses are frequency selective and are played in 
combination with magnetic field gradients thus leading PRESS to be capable of three-
dimensional localization of a cubic voxel. The three slice selective pulses in combination 
with the gradients are applied perpendicular to each other so that only spins in the Val 
are excited to produce a signal. Signal outside this volume is either not excited or not 
refocused, leading to rapid dephasing of signal by TE crusher magnetic field gradients. 
Slice profiles for selective 1800 pulses tend to be worse than than 900 pulses. This results 
in worse voxel shape and localisation compared with some other techniques (e.g STEAM). 
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1800 pulses also require a larger power output than 900 pulses. 
The PRESS sequence becomes increasingly dependent on T2 as the time between 
the first and second pulse is increased. This makes PRESS less suitable for detection of 
signals with short T2. 
TEt/2 TEt/2 + TE:J2 TE:J2 
RF 
~ ~ ~ I - - ~ I - - - - - - - - - -
Gx I I 
Gz 
Figure 2.11: The PRESS sequence: the block coloured markers (blu)indicates the crushers 
gradients whereas the continuous line indicates the selection gradients. 
J PRESS 
In the localized spectroscopy, in order to resolve the scalar coupling fine structure as 
well as the chemical shifts of the spectra, a PRESS sequence is adapted to acquire a 2D 
spectrum. The J-PRESS consists of several PRESS sequences where the echo time is in-
creased at each step. The final result is then several spectra at different TEs. Commonly, 
the coupling structure is more visible in the frequency domain so that the TE is consid-
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ered as a new fictitious temporal variable and a new further Fourier transformation is 
performed along that variable. Similarly to the line-broadening for 1D spectra due to T'; 
effect, a line broadening is visible along the fictitious variable. In this case, the linewidths 
are governed only by T2 effects if diffusion effects are neglected. Due to the signal loss 
related to T2 relaxation, the value of the max echo time is limited. The use of this new 
degree of freedom permits to spreading out the resonances which would be overlapped 
otherwise thus reaching a better identification of each metabolite. 
2.3.2 Stimulated Echo Acquisition Mode Spectroscopy (STEAM) 
Like PRESS, STEAM is a localization technique to perform a spectroscopy acquisition 
from a volume in a single acquisition. The essential difference is that STEAM utilizes 
three slice-selective 90 0 pulses and localization is achieved on a spatially selective stim-
ulated echo, rather than on a spin echo as in PRESS. Before describing the STEAM 
localization technique it is informative to consider the basic pulse sequence (without 
magnetic field gradients). As Hahn described Hahn EL [1950], any pair of RF pulses, of 
any flip angle, can form a Hahn or partial echo, and each echo can be further refocused 
by a subsequent RF pulse. The Hahn echoes are smaller in magnitude than spin echoes 
and have a T2 dependence. This pulse sequence generate eight echoes and three FIDs. 
Figure 2.12 shows on the top the signals which the sequence can generate. 8123 is the 
signal occurring at position 2TM (TM=mixing time) and is due to refocusing by pulses 
2 and 3 of magnetization excited by pulse 1. STE is the stimulated echo and occurs at 
T E + TAl. In the spectroscopy experiments, the STE is the signal of interest, while the 
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Figure 2.12: The STEAM sequence with slice selective gradients. 
S123 is the signal with similar coherence pathway as it is in PRESS. 
As it can be seen in figure 2.13, the first 9 0 ~ ~ pulse in combination with its respective 
gradient rotates all the spins into the transverse plane (A). During a time of T f after 
the first pulse, the magnetization dephases for the effect of TE crusher gradient and Bo 
inhomogeneities (B). Following that a second pulse ( 9 0 ~ ) ) is applied perpendicular to the 
first, which rotates this magnetisation into the xz plane (C). During time TM, the mixing 
time, between the second and third pulses 50% of this magnetisation (i.e. all transverse 
component) is dephased by the TM crasher gradient and only a net coherent longitudinal 
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Figure 2.13: Stimulated echo formation in a STEAM sequence. See text for details. 
component remains (D). Dephasing the magnetisation meanS it will not contribute to the 
'stimulated echo' . The third 90° pulse rotates the remaining magnetisation back into the 
xy plane (E) where a second, matched TE crasher gradient refocuses at time T E + T M 
to give the stimulated echo (F). In order not to have spurious signals in STE such signals 
have to be eliminated. This indeed can be achieved by placing a crusher gradient in the 
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T M period which eliminates all spin-echos and leaves only the STE and FID component 
arising from the last excitation pulse. The FID component can easily be eliminated by 
including identical crusher gradients in both TE/2 periods. 
One of the main problems with STEAM is the loss of 50% of the signal leading to 
only half the theoretical signal to noise compared with sequences such as PRESS. On the 
other hand, STEAM has two advantages which are the excellent localization accuracy 
and the extremely short echo-time (down to 1 ms Tkac ct al. [1999]), while the TM period 
(in which the magnetization is along the longitudinal axis) can be used for additional 
water suppression. Compared to the PRESS sequence, the STEAM sequence has also a 
lower power deposition due to the use of slice selective 90° rather than 180° pulses. 
2.3.3 Chemical Shift Displacement 
Frequency selective RF pulses in combination with magnetic field gradients cause the 
spatial position of the localized volume to be linearly dependent by the chemical shift 
of the compound under investigation. According to following equation the frequency 
depends on: 
(2.39) w(r) = w(O) + ,r . G 
and in a single direction it becomes: 
(2.40) w(x) = w(O) + ,xGx 
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Then, the position x is given: 
(2.41 ) x= 
W(x) - W(O) 
,Gx 
Two different compounds having two different Larmor frequencies will have a relative 
displacement b.x between their localized volumes given by: 
(2.42) b.x = b.w = b.w v: 
,Gx b.wmax x 
where b.w represents the difference in Larmor frequencies and where the gradient strength 
,Gx to select a given voxel size Vx in the x direction is proportional to the spectral 
bandwidth of the RF pulse b.wmax . 
An example of a strong effect at 3T is for water and lipids. The difference in Larmor 
frequency between water and lipids at 3T equals 3.7 ppm (469 Hz). By considering the 
bandwidth (1354 Hz) of the two 1800 refocusing pulses in the PRESS sequence present 
in the 3T Philips Achieva and a 3 x 3 x 3 cm3 volume, the displacement between the 
water and lipid resonances is around 1 cm in each direction selected by the 1800 pulses. 
This could result in misinterpretations of absolute concentrations when tissue, Bo or BI 
heterogeneity plays an important role. 
Furthermore, positioning the voxel in areas close to the skull could lead a severe 
spectral lipid contamination. This is completely independent from the accuracy of the 
localization of water as well as metabolites close to the water and can determine an erro-
neous absolute metabolite quantification. Importantly, non-coupled spins system such as 
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lipids and water do not present either any signal loss or time-dependent signal modula-
tions. That indeed is the case of homonuclear spin systems which have j-coupling within 
the same metabolites and resonate at different frequencies. 
Consider a homonuclear scalar-coupled AnX (n=l, 2, 3) spin system. In the case of 
n spin half-nuclei, the NMR spectrum will consist of an A doublet of relative intensity 
n and an X (n+l) multiplet of relative intensity one. Since similar conclusions can be 
reached about the X multiplet behaviour, we focus only on the A doublet. Figure 2.14 
A shows the two dimensions of the voxel selected by the two 1800 refocusing pulses for 
spin A. Because of the chemical shift artifact, the voxel for the X spins is shifted in all 
three dimensions by the amount given in Eq. 2.42 . This has the consequence that not 
all X nuclei within the A voxel experience the two 1800 pulses. 
In particular, evolution in the voxel is not homogeneous across the two directions. In 
all four subvoxels both pulses refocus the X nuclei transverse magnetization. In subvoxel 
1, both pulses also refocus the transverse component for A nuclei. At the same time, 
only the first RF pulse refocuses the transverse component of A nuclei in subvoxel 2, 
whereas the second RF pulse has no effect on that due to the chemical shift effect in that 
direction. In subvoxel 3, the first RF pulse has no effect on the transverse component 
of A nuclei due to the chemical shift effect in that direction, whereas the second RF 
pulse refocuses its magnetization. Finally, in subvoxel 4 none of the RF pulses affect A 
nuclei. Therefore, in the presence of chemical shift displacement, the modulation pattern 
substantially deviates from the ideal co-sinusoidal modulation. Especially for echo times 
between 1/ J and 3/ J the signal intensity is substantially reduced to zero when compared 
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Figure 2.14: from Graaf and Rothman [2001j. Effect of PRESS localization 011 the J-
evolution of coupled spins. (A) Displacements of the two-dimensional volumes for spin A 
(solid line) and for spin X (dotted line) as selected by the two 1800 pulses. (B) J-evolution of 
the A spins in an AXn n=l, 2, 3 spin system as a function of the echo time TE (TEl = TE2)' 
The curves represent voxel displacements of 0 ideal, 20, and 40% of the nominal volume. 
(C) J-evolution for AnX spin systems during an asymmetric PRESS sequence (TEl = 4TE2) 
with voxel displacements of 0, 20, and 40% of the nominal volume. 
to the ideal situation (sec figure 2.14 B). 
Asymmetrical PRESS sequences with (TE2=4TEI present even more complicated sig-
nal modulations (figure2.14 C) . From Fig. 2.14 it is evident that an enormous underes-
timation of the real concentration results if the chemical shift displacement effect is not 
taken into account. 
In order to either minimize or eliminate the unwanted modulations, Yablonskiy et al 
( Yablonskiy et al. [1998]) provided a very straightforward solution based on the increase 
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in the RF bandwidth. The chemical shift displacement artifacts gets more severe at higher 
magnetic fields and the artifact can only be minimized by increasing the magnetic field 
gradient strength, which (for a constant voxel size) corresponds to an increase in spectral 
bandwidth of the RF pulse. Unfortunately this option has only limited applicability 
because the required RF power increases with decreasing pulse length. An increase in 
RF power implies in turn an increased specific absorption rate (SAR)2. On the majority 
of the human systems one would typically encounter the SAR limitation well before any 
gradient strength limitations. 
2.4 Spectra quantification 
2.4.1 Fitting algorithms for spectra quantification 
In the last two decades, several in vivo NMR signal processing methods for spectra quan-
tification were developed and a substantial improvement for the estimation of metabolic 
concentrations was made. The new advanced techniques of fitting and the availability of 
more powerful computers have inspired the creation of new softwares which are much 
more complex than simple integrations used early on. 
Very popular fitting algorithms include the jMRUI package (Naressi et al. [2001]), 
which has got as tools the VARPRO and AMARES (Vanhamme et al. [1997]) programs, 
2The SAR keeps into account the electric component of the RF which is dissipated as heat in the 
conducting material. The specific absorption rate is typically expressed in uuits of watts per kilogram. 
The deposited power P during a RF pulse of length T is proportional to the square of the irradiating 
RF field according to : 
(2.43) 
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Figure 2.15: Fit of point-resolved spatially localized 1 H MR spectrum TE=80 ms at 3T 
performed by using LCModel. 
LCModel (Provencher [1993, 2001]) and others (Slotboom et al. [1998] Wilson et al. 
[2010]). 
The total NMR signal can be considered as linear combination of the NMR signals 
from the pure or isolated compounds. This forms the basis for so called linear combination 
(LC) modeling algorithms (LCModel) as it was firstly described by de Graaf and Bovee 
and successfully embedded in a popular program by Provencher through the LCModel 
program. With LC modeling algorithms the measured NMR spectrum (typically H) is 
approximated as a linear combination of metabolite NMR spectra, which commonly re-
ferred to as a basis set . The algorithm works only in the frequ ncy domain. This mean 
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that all procedures of fitting are performed on real part of the Fourier Transformation 
(FT) of the FID. These fitting methods are not exclusive of the frequency domain but 
are also similarly utilized by other algorithms in the time domain. Depending on the ap-
plication, the basis set have to be extended with additional metabolites as necessary. The 
completeness of the basis set is extremely important, i.e. all metabolites that are present 
in the in vivo NMR spectrum should be included in the set. The omission of a single 
metabolite from the basis set might lead to a systematic bias in the estimated parameters 
and in particular the amplitudes and the concentrations of the other metabolites might 
be under/overestimated. The reason is because metabolite amplitudes are typically cor-
related with each other depending on the amount of spectral overlap. The inclusion of 
'basis set' metabolite not actually present in the spectrum to quantify does typically not 
generate error or bias because the amplitude of any nonexistent metabolite can simply 
be set to zero. However, a larger amount of metabolites implies longer calculation times 
and a slower convergence. 
In principle, all LC modeling algorithms work by varying amplitudes, frequencies, line 
widths and phases of the metabolite basis set such that the modeled spectrum match-
es the in vivo NMR spectrum as close as possible. The usual procedure relies upon 
least-squares function minimization. The algorithm adds also both soft constraints on 
the fitting parameters and regularizors in order to achieve faster convergence and to 
avoid to reach local minima. In addition, short echo-time 1 H NMR spectra are typically 
characterized also by a significant macromolecular baseline. In order to achieve a mean-
ingful spectral fitting result and also to extract useful information from the components 
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contributing to the baseline, the macromolecular and lipidic resonances have to be tak-
en into account. The baseline is computed with a cubic spline polynomial function but 
this introduces a large number of further fitting parameters that are not based on bio-
physical parameters. Therefore, it is possible to overcome these issues by measuring the 
contribution to the spectra baseline and by including that into the fitting. The baseline 
component can indeed be selectively detected, By using the fact that Tl and T2 relax-
ation times of macromolecules and lipids are significantly shorter compared to those of 
metabolites. Besides, it can be seen that the residual background or baseline signal is 
very small and can be simply approximated with a low-order polynomial function. A 
small residue between the fitted and measured NMR spectra does not guarantee a good 
fitting accuracy whereas a large residue is surely a indicative of a poor spectral fit and 
hence of a not reliable estimation. This explains the reason why it is important to find a 
measure for the error of estimated parameters, and in particular for the concentrations, 
in order to assess the accuracy of the fit. 
2.4.2 Cramer Rao Lower Bound (CRLB) for fitting error estimation 
In order to have a quantitative confidence of the estimated parameters, it is essential to be 
able to associate an error to them. That permits either to keep or reject the parameter 
estimate. One of the main problems of the quantification is that the concentration is 
obtained from one spectrum only and the standard deviation cannot be calculated with 
usual statistical tests. So, for a given noise level the lowest possible estimator-independent 
errors are given by the so-called Cramer-Rao lower bounds (CRLBs) (Cavassila et al. 
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[2001]' Cavassila et al. [2000]). For a proper evaluation of the CRLBs the experimental 
data must be fitted with an exactly known model function. The used model functions are 
only partially corresponding to the real data and as such the calculated CRLBs are only 
approximate. This is especially true and problematic for data which lacks of a specific 
model function, such as macromolecular resonances in short echo-time 1 H NMR spectra. 
The CRLBs are independent from the fitting algorithm so that they equally well apply 
to the time and frequency-domains. 
In mathematical terms, supposing that the noiseless data can be exactly modeled by 
the complex-valued either time or frequency domain model function xn, n = 0, ... , N-1, 
the experimental data Xn can be written as: 
(2.44) 
where bn is Gaussian-distributed noise. Evaluation of the CRLBs requires the operation 
of inversion of the Fisher information matrix F which can be expressed as 
(2.45) 
where 
(2.46) for n=0,1"N-1 and 1= 1,2, ... ,Np. 
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The size of F is equal to the number of free real parameters to be estimated. The matrix 
P is the prior knowledge matrix. The superscript H indicates Hermitian conjugation, R 
stands for real part and a is the standard deviation of the real and imaginary part of 
the noise. The vector p = (Pl,P2,··· ,PNpf represents the Np real model parameters. To 
compute the matrix D the calculation of the derivatives of the functions .1:n with respect 
to the parameters PI using their true values has to be performed. Incorporation of prior 
knowledge and hence the interrelation among the parameters themselves in turn reduces 
the number of free parameters and consequently the size of the information matrix F. 
For instance, if we assume a linear relations between model parameters, such as PI = aPm 
and PI = Pm + b, in which a and b are real constants, we can write the prior knowledge 
matrix P as the matrix of partial derivatives: 
for l=O,l, ... ,Np and m = 1,2, ... ,L. 
p' = ( p ~ , , p ~ , , ... , PN )T corresponds to the L unconstrained parameters PI to be estimated. 
p . 
When L = Np, P is exactly the identity matrix. The relation between CRLBs and the 
standard deviations of the estimated parameters PI is given by the Cramer-Rao inequality 
(2.47) 
In the particular case of computation of CRLBs of concentrations, en, the computation 
becomes much easier for the presence of linear parameters. In this case, if the model is 
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described by CS:n(Pl) where now the Pl are only the non-linear parameters, the D matrix 
simply becomes: 
(2.48) 
whereas the Fisher information matrix F is computed by the linear algebraic product: 
(2.49) 
It is generally accepted that metabolite concentrations with CRLB < 20 % are mea-
sured with sufficient precision whereas metabolites exceeding 20% should be considered 
with caution. However, a small CRLB is not a guarantee for an accurate metabolite 
concentration since an incorrect or incomplete metabolite basis set might also lead to 
bias the results despite the very low CRLBs. As it can be noticed from the Fisher matrix 
in equation 2.45 and from expression of the matrix D, the CRLBs increase both with 
increasing noise level, and with increased spectral overlap. 
An estimate of this overlap in an NMR spectrum can be calculated through the 
so-called parameter correlation matrix that delineates the correlation Pmn between pa-
rameters Pm and Pn according to: 
~ ~Pmn = ---:===-,m.:.:.n,::== J F ~ ! n J F ~ ~ ~
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This matrix highlights that, in the presence of noise, strongly correlated concen-
trations, like those obtained for creatine and phosphocreatine, might lead to erroneous 
quantification. In those cases, and more specifically when the correlation are larger than 
0.5, it is more meaningful to report the values associated to the combined pool, e.g. total 
creatine, which is typically more reliable and accurate. 
2.5 Two Water Suppression Techniques: Frequency selective exci-
tation and VAPOR 
The main problem encountered during in vivo 1H MRS studies is that the water signal 
is 10.000 times as abundant as the metabolite concentrations. The large water signal 
may then distort the baseline and vibration-induced sidebands of the water obscure the 
metabolite resonance. Therefore, the water signal needs to be suppressed. 
The methods of water suppression rely upon differences in magnetic properties be-
tween the water molecules and the other metabolites. Thus, differences in chemical shift , 
scalar coupling, Tl and T2 relaxation, diffusion and exchange can also be exploited. 
No complete explanation of all techniques for water suppression will be provided but 
rather the methods utilized throughout this work will be described: frequency selective 
excitation and VAPOR. 
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2.6 Frequency selective excitation method 
This approach consists of a selective RF pulse which excites the water magnetization onto 
the transverse plane followed straight after by a lllagnetic field gradient which dephases all 
the coherences. The sequence was originally suggested with the name CHESS (CHEmical 
Shift Selective) (Haase et at. [1985]). CHESS is able to leave the metabolite resonances 
unperturbed and for this reason it can be added at the beginning of any pulse sequences. 
The delay between CHESS sequence and the first excitation pulse need to be as short 
as possible to reduce the signal recovery due to T1 · CHESS efficiency strongly depends 
on the RF pulse performance in selectively exciting the all water magnetization. Hence, 
the homogeneity of Bo and Bl is a key point and a single CHESS element would be 
sufficient for an accurate water suppression. In practice, the homogeneity is not ideal and 
several CHESS elements (two to six elements) must be sequentially placed to improve 
the suppression. Then a series of CHESS elements uniform the suppression to a large 
range of frequency thus making the suppression less sensitive to frequency offsets caused 
by Bo magnetic field inhomogeneity. Furthermore, the performance depends also on the 
nutation angle and the suppression is perfectly reached only at 90°. In particular, if the 
relaxation is not taken into account, the residual longitudinal magnetization M(O) after 
n CHESS elements is a function of the nutation angle Mz(O) = Mo cosn(O). 
Therefore six CHESS elements would lead the residual magnetization along the z axis 
to be less than 0.035 % for nutation angles, 75° :S 0 :S 105°, providing sufficient water 
suppression with a tolerance to the magnetic field inhomogeneity of 30 % around the 
nominal nutation angle of 90°. 
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Some methods have investigated the possibility to create more Tl and Bo insensitive 
CHESS-based water suppression methods by optimizing the inter-pulse delay and the 
nutation angles of the different CHESS elements (Ogg et al. [1994]). 
2.7 VAPOR method 
The VAPOR method uses optimised frequency-selective perturbations interleaved byop-
timal TI recovery delays to make the suppression insensitive to T} and Bo inhomogeneity. 
The VAPOR method is reported in figure 2.16. It consists of seven CHESS suppression 
and seven Tl recoveries. For a nutation angle f3 of 95°, the longitudinal magnetization 
prior to nonselective excitation ends up very close to zero despite the presence of Tl 
relaxation. Even when the nutation angle is not corrected calibrated (see different angles 
on figure 2.16), the magnetization reaches values close to zero due to the optimized pulse 
and delay combination. 
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Figure 2.16: From Tkac et al. [1999J . Seven CHESS water suppression scheme (VAPOR) 
with optimized flip angles and timing. 
2.8 Proton MRS in the human brain 
The proton nucleus is the most sensitive nucleus for NMR with a high natural abundance 
(> 99.9 %) and intrinsic NMR sensitivity (high gyromagnetic ratio). Since nearly all 
metabolites contain protons, in vivo 1H NMR is used to study the human brain in vivo 
for the detection of a number of important metabolites, such as the ones reported below. 
An example of a rat brain proton MR spectrum is reported in figure 2. 18. 
N-Acetyl Aspartate (NAA) NAA is an amino acid present in the brain in relative 
high concentrations. Being such an abundant metabolite, and having a very high 
single peak, NAA has been extensively studied in vivo especially for the psychi-
atric and neurologic clinical applications (Birken and Oldendorf [1989], Rudkin 
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and Arnold [1999]). In particular, NAA is used as a marker for neuronal density 
in the brain because of the observed decrease in NAA concentration in disorders 
such as stroke, tumours and multiple sclerosis that present neuronal loss. Decrease 
in NAA concentrations can also be associated with neurodegenerative disease such 
as Parkinsons and Alzheimers diseases. The presence of NAA has also been found 
in other cells (Urenjak et al. [1992]). The metabolic function of NAA is still not 
completely understood, but several hypotheses have been suggested regarding its 
role in fatty acid and myelin synthesis (D 'Adamo and Yatsu [1966], D 'Adamo et al. 
[1968]) and as a breakdown product of the neurotransmitter NAAG (Blakely and 
Coyle [1988]). 
Glutamate (Glu) and Glutamine (Gin) Glu is the most abundant amino acid in 
the brain and is the main excitatory neurotransmitter. Its concentration ranges 
between 6 and 12.5 roM with significant differences between gray and white matter. 
Glu is present mostly in glutamatergic neurons and also in GABAergic neurons and 
astroglia. 
GIn is an amino acid synthesised from Glu by GIn synthethase in the astroglia and it 
is broken down to Glu by phosphate-activated glutaminase in neurons. The Glu-Gln 
neurotransmitter cycle is presented in figure 2.17 Understanding the Glu and GIn 
role in metabolism is crucial to investigate neurotransmitter activity. Unfortunately, 
in proton spectroscopy their peak overlap thus leading to the need of high and ultra-
high magnetic field strengths. For this reason, it is sometimes useful to give the 
combined concentration of Glu and GIn, given as Glx (Glu+Gln). 
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,),-Aminobutyric Acid (GABA) GABA is the main inhibitory neurotransmitter, present 
in the brain with concentrations of about 1 mM, and is linked with the metabolism 
of GIn and Glu. Changes in GABA concentrations in the brain are associated with 
neurological and psychiatric disorders. As for the Glu and GIn, at low magnetic 
fields, there are strong coupling effects. 
Choline (Cho) In proton MRS, Cho shows a peak at about 3.2 ppm which is the sum 
of three different contributes: free choline, Glycerophosphorylcholine (GPC) and 
Phosphorylcholine (PC). The term "total choline" (tCho) is often used to refer 
to this peak. The interpretation of the changes in the tCho peak observed with 
MRS in vivo is therefore complicated by the multiple contributions from different 
metabolites. However, the concentrations of Cho has been found to be varying in 
some pathologies such as stroke, tumours and neurodegenerative disorders. 
Creatine and Phosphocreatine (ere, PCre) Cr and PCr are present in the brain, 
blood and muscle and are normally absorbed by the body from food in the diet. 
The peak from Cr+PCr is very high (after NAA peak) and stable being relatively 
constant in healthy and diseased brain. Therefore it is often use d as a reference for 
proton MRS in vivo. However, some changes in Cr and PCr concentrations have 
been reported in some illnesses such as stroke and tumours. 
Others Other metabolites that can be studied with proton MRS include Aspartate 
(Asp), Acetate (Ace), Lactate (Lac), Myo-inositol and Scyllo-inositol. 
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Table 2.1 reports the typical ranges of metabolic concentration measured in the human 
brain with 1H MRS. 
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GIn . 
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Figure 2.17: From Graaf and Rothman [2001J . Four-compartment metabolic model com-
prising the blood/plasma, glutamatergic neurons, GABAergic neurons and astroglia. Glu-
cose enters the brain with the aid of glucose transporter in the bloodUbrain barrier. In 
the glycolytic pathway, glucose is broken down into two pyruvate molecules which enter 
the tricarboxylic acid (TCA) cycle. One of the TCA cycle intermediates, 2-oxoglutarate 
(20G) , is in rapid exchange with a large glutamate pool that can be observed with NMR. 
The TCA cycle flux can be obtained from the glutamate turnover and is denoted VT-
CA. Due to compartmental localization of specific enzymes, the fate of glutamate differs 
in each of the three cellular compartments. In glutamatergic neurons, glutamate acts as 
an excitatory neurotransmitter and is released into the synaptic cleft in response to an 
action potential. Following interaction with post-synaptic receptors, the glutamate is tak-
en up by the astroglia and converted to glutamine. Glutamine is ultimately transported 
back to the glutamatergic neuron, where it is converted to glutamate, thereby complet-
ing the so-called glutamate-glutamine neurotransmitter cycle. The flux through this cycle, 
Vcycle,Glu/Gln, can be obtained by following the glutamine turnover. In the GABAergic 
neuron, the glutamate is first converted to GABA which is the primary inhibitory neu-
rotransmitter. Similar to the glutamatergic neuron, a GABA-glutamine neurotransmitter 
cycle exists between GABAergic neurons and astroglia. A metabolic pathway specific to 
astroglia is the carboxylation of pyruvate catalyzed by the astroglia-specific enzyme pyru-
vate carboxylase (PC) . Note that the letter size roughly corresponds to the metabolic pool 
size of the corresponding metabolite (e.g. a large glutamine pool resides in astroglia). 
Metabolite 
NAA 
GABA 
(ho (total) 
ere (total) 
Glu 
Gin 
Myo-inositol 
Scyllo-inositol 
Concentration 
(mM) 
7.9 16.6 
1.3- 1.9 
0.9- 2.5 
5.1- 10.6 
6.0-12.5 
3.05- 5.8 
3.8- 8. 1 
0.3-0.6 
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Table 2.1: Metabolite concentrations measured with in vivo and ex vivo 1H MRS in the 
human brain. 
NAA 
tCr 
9.0 8.0 7.0 6.0 4.0 3.0 2 .0 1.0 0.0 
chemical shift (ppm) 
Figure 2.18: From R . A. De Graaf [2007j .Proton NMR spectrum obtained from rat brain 
in vivo at 11 .75 T (TRITE = 4000/12 ms). 
Part II 
MRS applications in Schizophrenia 
---3 
Reproducibility of neurotransmitter pool estimates 
using optimised MRS protocols on a clinical scanner 
operating at 3.0 Tesla 
3.1 Introduction 
Several IH-MRS acquisition schemes have been proposed and a special interest was 
dedicated to implement editing sequences and to optimize timing parameters either to 
accurately resolve overlapped metabolites or to quantify metabolites otherwise obscured 
by highly concentrated compounds. In fact, some studies showed how particular TE 
values are optimal to suppress some overlapping peaks and to simplify the quantification 
of metabolites of interest . More refined techniques tri ed to optimize the TEl and T E2 
(T E /2 = TEl + T E2) since different j-coupling modulation occurs by varying th two 
terms and keeping the echo time fixed as it has been showed for citrate (Gambarota et al. 
[2005]). 
Furthermore, even if j-editing methods were proved to be able to provide a reliable 
quantification, there is still lack of studies demonstrating a real improvement in reliabil-
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ity over standard 1H-MRS for the in vivo measurement of Glu, GIn, GABA, and other 
metabolites. Secondly, difficulties of implementation reduce their use for clinical pur-
poses. This study aims to compare the reliability of conventional and timing-optimized 
sequences for the detection and measurement of most of the visible metabolites and, in 
particular, for Glu, GIn and GABA. The reliability is assessed by computing two param-
eters: test-retest reproducibility coefficients of variation (CV) that provide an estimate 
of measurement stability and CRLI3 values (Cramer Rao Lower Bound) for the fitting 
quality estimate. The test-retest goal is also to determine the best sequence capable of 
detecting and robustly quantifying both neurotransmitters, such as Glu and GABA, and 
a metabolite which is biochemically linked to them, GIn. A particular interest is given 
in testing whether the sequences are able to quantify and then to provide concentrations 
for a wide range of metabolites. 
3.2 Methods 
The study was approved by the local Medical School Ethics committee and 14 healthy vol-
unteers were recruited. All volunteers gave written informed consent. The MRI protocol 
consisted of a structural imaging MPRAG E and 7 spectroscopy sequences: 
• PRESS TE=80ms (P80)(Schubert et al. [2004]); 
• PRESS TE=40ms (P40)(Muilins et al. [2008]); 
• PRESS TE1=30ms, TE2=85ms (P115)(Snyder J [2009]); 
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• PRESS TE1=90ms, TE2=18ms (P108)("ISMRM abstract:" 4283 [2009]); 
• STEAM sequence TE=14ms, TM=8ms (814(128»), 128 averages; 
• STEAM sequence-TE=14ms, TM=8ms (814(256»), 256 averages; 
• STEAM TE=72ms, TM=8ms (872)( Yang et al. [2008]). 
A 3T Philips Achieva scanner (software release 2.5.3) equipped with 8 channel sense 
coil was used and each subject underwent two different sessions separated by 10 minutes. 
In order to shorten the acquisition on each subject a single spectrum per sequence was 
acquired. In order to reproduce the variability due to subject repositioning, subjects were 
taken out the scanner between the sessions. A 25x25x25 mm3 voxel was positioned in 
the prefrontal cortex (see figure 3.1) and the same values of TR=3000ms and of NA=128 
were set up for all sequences. Due to smaller SNR compared to PRESS, which has total 
acquisition time of 6 minutes, one of the STEAM sequences (814(256») was acquired 
with 256 averages in order to exclude any possible SNR-dependent bias. All spectra 
were analyzed with LCModel and every basis-dataset was simulated with Spinevolution 
software version 3.3.3 (Veshtort and Griffin [2006]). The test-retest reproducibility was 
defined by coefficients of variation (CV): they were expressed as the absolute difference 
in concentration between scan 1 and scan 2 divided by their average concentration for 
each metabolite. For each metabolite, the computed CVs per sequence were statistically 
tested to check whether the differences in the CVs' mean values among sequences were 
also statistically significant. The T-test was performed by using the Matlab statistic 
toolbox. 
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Figure 3.1: Voxellocalization in the prefrontal cortex of healthy volunteers. 
3.3 Results 
Most of the data showed good fitting for the main metabolites and a narrow linewidth 
equal to 0.02 ppm. The values for CRLB and CV a selection of the metabolites of 
interest are shown in the table 3.3. The STEAM protocols usually performed more poorly 
compared to the PRESS protocols even though the myo-Inositol quantifications obtained 
a more reliable quantification in the case of STEAM. There was a significant difference 
between all the PRESS sequences and the short TE STEAM with 128 averages but no 
statistical improvements among the STEAM sequences. Not surprisingly the STEAM 
TE= 72ms did not perform well for any metaboli tes, most likely caused by the long TE 
wherc part of the signal is lost . Convcrsely, the Glu was fitted and quantified better 
with longer TE but the P80 revealed a more valuable quantification also for the GIn. 
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Table 3.1: Mean value of fisher correlation coefficients between Glutamate and Glutamine 
quantifications for all sequences in healthy volunteers. 
Sequence P1l5 P80 P40 P108 S14(128) S14(256) S72 
GIu-Gln corr 0.019 0.036 -0.063 0.1 0.045 0.048 
No evident difference was observed in thc PRESS protocols when a statistic test was 
applied to the Glu and NAA CVfi. From figure 3.3 it is possible to calculate the mean 
value among all seqnences for the coefficientfi of variation for Glu equal to (mean±SD) 
1O±3, 872 has been excluded because it is unreliable. It can also be seen that GIn 
has the minimum value, (mean±SD) 12±9, corresponding to P80. In fact, as shown 
in figure 3.2, the GIn CVs showed also a statistically significant difference among the 
different sequences (P115-P80: p<0.004; P40-P80: p<0.03; PI08-P80: p<O.Ol). In 
general, P80 has shown a robust detection and accurate reproducibility for a wide range 
of metabolites failing, in comparison to other sequences, for Ins and Asp. In addition Glu 
and GIn theoretical correlation coefficients were computed (see table 3.1); apart from the 
PI08 the correlations appeared to be quite low proving a sufficient distinction between 
the two metabolites. Interestingly, P80 reported also a low correlation value (0.036). 
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(a) NAA (b) Ins 
I 
"que", .. 
(c) Glu (d) Asp 
uquenus 
(e) GIn (f) GPC+ PCh 
Figure 3.2: (Mean ± SD) Test-retest stability in healthy volunteers (prefrontal cortex) 
coefficients of variation (CV) for major metabolites and for all sequences under investi-
gation. The significant differences with p< O.05 are indicated with an asterisk. The CVs 
are computed as the absolute value of 2 x g ~ ~ + g ~ ~ where the C1 and C2 are concentration 
estimates from the respective measurements. See text for details. 
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Sequences PI08 P11S P40 P8D 514_128 572 514 256 
NAACV 4 5 10 9 5 4 6 
NAACV(STD) 3 5 17 16 4 3 4 
NAACRLB 2 1 2 2 2 2 2 
InsCV 28 14 8 11 3 16 6 
Ins CV (STD) 13 18 7 8 2 10 2 
InsCRLB , 15 6 5 6 4 6 3 
GluCV 7 6 13 9 13 17 13 
GluCV(STD) 7 5 20 13 11 13 9 
GluCRLB 5 4 6 5 7 11 6 
GlnCV 22 37 21 12 78 24 
Gin CV(STD) 11 27 14 9 80 13 
GlnCRLB 14 20 19 14 122 788 17 
GABACV 63 29 31 28 68 41 32 
GABA CV (STD) 60 17 25 30 44 31 27 
GABACRLB 75 21 34 25 38 33 29 
CreCV 6 17 15 12 19 15 27 
Cre CV(STD) 4 9 17 10 8 4 22 
CreCRLB 9 10 8 10 11 10 11 
AspCV 11 90 20 31 93 20 
AspCV(STD) 11 69 18 26 75 11 
AspCRLB 13 168 936 14 23 43 21 
TauCV 35 27 16 22 113 23 
Tau CV(STD) 30 28 15 18 84 18 
TauCRLB 390 26 21 24 14 244 ~ ~ 14 
PCrCV 7 20 17 20 16 19 28 
PCrCV(STD) 5 15 12 25 15 15 22 
PCrCRLB 10 10 10 10 12 12 9 
5cylloCV 30 34 19 36 16 39 29 
Scyllo CV (STD) 26 24 15 32 10 23 31 
5cylloCRLB 30 28 18 27 18 26 20 
GPCCV 16 14 16 14 11 9 27 
GPCCV(STD) 11 14 11 9 10 7 19 
GPCCRLB 8 5 8 7 15 7 11 
GuaOl 19 35 10 16 64 53 23 
Gua CV(5TD) 14 39 12 15 77 83 7 
GuaCRLB 18 23 9 10 111 122 12 
GPC+PChCV 14 16 17 18 13 10 30 
GPC+PCh CV (STD) 10 13 17 13 5 8 25 
GPC+PCh CRLB 11 7 10 9 14 7 12 
Figure 3.3: Test-retest stability in healthy volunteers' spectra from prefrontal cortex. 
Mean±SD coefficients of variation (CV) and Cramer-Rao-Lower-Bounds (CRLB) are given 
for major metabolites and for all sequences under investigation . CV (%) =2 x 100 x G1 -G2 
. . ~ + ~ ~
where the Cl and C2 are concentratlOn estImates of each measurements. See text for details . 
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3.4 Discussion 
The present comparative study shows that Glu, GIn can be reliably measured on pre--
frontal cortex and that can be achieved with no sophisticated editing technique. However, 
there is an important limitation of the values reported in this study to be considered: 
when different brain areas are investigated there could be a poor shimming performance 
leading to an increase in CRLBs and CVs. Also, even though it is not evident from our 
data, the sequences with longer TE would be quantified with a stronger T2 decay which 
is not easily eliminable. Despite that, P80 can be considered a good compromise if in-
terests are focused on variations caused by disease rather than absolute values. Given 
the fact that different sequences are resulted specific only for some metabolites and not 
reliable for others, in the case of not too stringent experiment time restrictions, the use 
of two sequences could cover a wider range of detected compounds and give enhanced 
results. Furthermore, the increment of number of averages in 814(256) did not prove 
to have any benefit compared to the 814(128), probably caused by the disadvantage of 
frequency shift occurring when longer acquisition time is exploited. Signal-to-noise ratio 
might get a further improvement by fragmenting the acquisition in dynamic mode and 
by acquiring 8 spectra of 16 averages each. Even though no realigning was performed 
(see appendix A) on those data, a gain in terms of SNR would have come from the Bo 
drift correction. Furthermore, it is also of particular importance to put in a context the 
reported Glu and GIn theoretical correlation coefficients: those values need to be relat-
ed to how correct the quantification reproduced the concentrations: underestimation of 
glutamine levels would produce low correlation coefficients which are not necessarily a 
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strong metabolite separation. Importantly, our CVs were also smaller than the CRLBs 
values and that seems to be not in accordance with estimators' theory. In fact, CRLBs 
are indeed the lower bound on the variance of estimators of a parameter and any un-
biased1 estimator should not be smaller than CRLBs. It is possible to prove that the 
variance used2 is a biased3 estimator thus proving the fluctuations of the CVs. Having 
said that, no direct prediction of CVs can be deducted from the CRLBs. 
As a rule of thumb we can generally accept that CRLB values ::; 10% predict CV 
values smaller than 20% and hence the correspondent quantification is acceptable and 
accurate. On the contrary, for CRLB values 2:10% no conclusions can be drawn. How-
ever, the discrepancy found between CRLBs and CVs is likely to be also associated to 
uncertainty due to subject repositioning. In fact, in this case there is a larger variability 
which cannot be predicted by a mathematical model. Excluding that further uncertainty 
might make CRLBs more associated to the real CV s. 
1 An estimator is said to be unbiased if the differellce between this estimator's expected value and 
the true value of the parameter being estimated is equal to zero for all values of the parameter. 
2Given independent and identically distributed random_variables >'1, ... , An having expectation value 
p, and variance 0"2. We have been llsing mean defined a.'l A = ~ ~ L ~ = 1 1 Ai and variance defined a.'l S2 = 
1 n -2 
n Li=1 (Ai - A ) 
3The bias can be proved by: 
(3.1) E[S2] = E [ ~ t ( A i i - X)2] = E [ ~ t t ((Ai - JI.) - (X _11.))2] 
(3.2) [ 1 ~ ~ 2 - 1 ~ ~ -] = E ~ ~ 6(Ai -p,) - 2(A - p , ) ~ ~ 6(Ai -p,) + (A -p,? 
(3.3) [ 1 ~ ~ 2 - 2] 2 [ - 2J = E - L./Ai - p,) - (A - p,) = 0" - E (A - p,) < ()2 
n i=1 
It can be proved that an unbiased estimator variance is instead: S2 = n ~ 1 1 L ~ = l l (Ai - X2) 
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3.5 Conclusions 
The PRESS TE=80ms was considered a good compromise for detection of Glu and GIn 
as well as other major metabolites. A big limitation of the sequence is due to the fact that 
GABA was not reliably quantified so that an optimization needs to be done to determine 
a sequence capable of measuring GABA concentration. The P80 reliability described in 
this chapter refers to healthy volunteers and to reasonably large voxel so that we may 
expect a reduced performance of the sequence in the case of patients and of smaller voxel 
size. 
--4 
Oscillatory brain activity and metabolic profile in 
schizophrenia investigated by proton MRS and EEG 
4.1 Introduction 
Schizophrenia is a severe mental disorder that affects about 1% of the population in the 
world (Chang et al. [2007]). The aetiology of schizophrenia is not entirely understood, 
but the disease involves abnormal dopamine and Glu transmission and, in particular, 
several lines of evidence point to a crucial role of hypofunction of NMDA receptors and 
resulting prefrontal glutamatergic dysfunction and neurotoxicity (Rusch et al. [2008]). 
Numerous studies about glutamatergic model of schizophrenia ( Olney et al. [1999], Farber 
et al. [2002]' Olney and Farber [1995]) established the so called glutamate hypothesis in 
schizophrenia. 
According to the hypothesis of NMDA receptor hypofunction, this hypofunction caus-
es decreased activity of inhibitory GABAergic interneurons (Carlsson et al. [2001]' Lewis 
and Moghaddam [2006], Homayoun and Moghaddam [2007], Coyle [2006], Coyle [2004]) , 
which leads in turn to the disinhibition of glutamatergic neurons projecting to the pre-
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frontal cortex and consequently an increase in Glu release (Moghaddam et al. [1997], 
Moghaddam and Adams [1998]). 
In vivo IH MRS has been widely used to study schizophrenia as it is able to look into 
alterations of metabolites that may result from NMDA hypofunction. Indeed, over the 
last two decades, a number of IH MRS studies have been performed as a consequence 
of this hypothesis in order to research possible alterations of Glu levels in schizophrenia. 
Findings to date are highly controversial and do not allow to conclude whether differences 
between studies are due to technical challenges in estimating Glu levels or to effects from 
disease heterogeneity, duration or medication. The anterior cingulate is surely a region 
where dysfunctions in schizophrenia have constantly been found and where several studies 
focused attention on. Different field strengths have been used, but this review will focus 
on those ~ ~ 3T to avoid confounds emerging from less reliable MRS reporting Glu/Gln 
rather than their separate quantification. Table 4.1 summarises the main studies at field 
strength ~ ~ 3T reporting Glu and GIn changes in schizophrenia. 
No evidence of changes was found in Glutamate+Glutamine (Glx) (Wood et ai. [2007]) 
in the right and left dorsal and rostral cingulated of 15 male schizophrenia patients when 
compared with 14 controls. A 9% NAA reductions was detected. 
Theberge and colleagues conducted several studies at 4 T field strength with voxel size 
of 1.5 cm3 . In their first study (Theberge et ai. [2002]) of 21 young never treated patients 
with schizophrenia (illness duration approximately 1.7 years) and 21 healthy volunteers, 
the patients presented an elevated GIn with normal Glu and NAA in both the left an-
terior cingulate and left anterior thalamus. This work, similarly to what a very first Glu 
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study had found (Bartha et al. [1997]), suggests an increased glutamatergic neurotrans-
mission! early in the illness, which is not attributable to either effects of medication or 
chronicity. The same group then studied 21 patients with chronic schizophrenia (illness 
duration approximately 15.6 years) and 21 controls (Theberge et al. [2003]). Glu and GIn 
were decreased in the anterior cingulate, but the left thalamus GIn was increased. They 
concluded that in the Anterior Cingulate Cortex (ACC) of chronic patients decreased 
levels of Glu and GIn could be related to n e u r o d e ~ e n e r a t i o n n or to the effects of chronic 
medication. On the contrary, increased glutamatergic turnover persisted in the thalamus 
while the glutamatergic system gets reduced earlier in the cingulate, suggesting disease 
progression or antipsychotic medication effects. The same group carried out a longitudi-
nal study in 2007 (Theberge et al. [2007]) in which they focused attention on Glu, GIn and 
gray matter volume in the left anterior cingulate and thalamus of 16 patients with first-
episode schizophrenia at baseline. After that, two different scan sessions took place: after 
10 and 30 months of antipsychotic treatment. 16 healthy participants underwent MRI 
on two occasions 30 months apart. The study reported higher GIn levels in the ACC and 
thalamus of never-treated patients, consistent with their first study (12 out of 16 subjects 
overlapped with the cohort of their 2002 study). After 30 months, the anterior cingulate 
GIn level were consistently increased, which is in contrast with what they showed in their 
2003 study on patients with longer duration of illness. The reduction in the thalamus GIn 
level was significant after 30 months, but that decrease did not drop below the healthy 
IThe association of Gin changes to glutamatergic neurotransmission is due to the well known hy-
pothesis that in glutamatergic neurons, Glu acts as an excitatory neurotransmitter and is released into 
the synaptic space in response to an action potential. Following the interaction with the post-synaptic 
receptors, the Glu is taken up by the astroglia and converted to Gin. 
Introduction 75 
---------- --------- ----
control level; parietal and temporal lobe gray-matter loss was correlated with thalamic 
GIn loss. No significant changes were observed in Glu and GIn over 30 months in the 
healthy group. They speculated that elevated GIn in never-treated patients with a subse-
quent decrease in thalamic GIn and gray-matter loss in connected regions could indicate 
either neurodegeneration or a plastic response to reduced subcortical activity. 
Furthermore, increased Glu and GIn levels were reported both in the dorsolateral 
prefrontal cortex and in hippocampus among subjects with chronic schizophrenia (van 
Elst et al. [2005b]). No significant correlation between duration illness duration and GIn 
concentrations was reported. 
Recent studies have looked at the possibility of using Glu/Gln MRS measures as 
potential schizophrenia endophenotypic markers. A comparison between 20 adolescents 
having a parent with history of schizophrenia and a group of 22 adolescents with no 
parents with a history of illness (Tibbo et al. [2004]) was made to assess difference between 
high and low genetic risk of schizophrenia. They found significantly higher Glx in the 
right medial frontal lobe of the high-risk group and this finding was considered in favour 
of a neurodevelopmental hypotheses for schizophrenia. 
In addition, among the psychological measures with endophenotypic relevance, the 
Continuous Perform?,nce Test (CPT) (BECK et al. [1956]) has received the most interest. 
Poor performance is often seen in people with schizophrenia on the CPT. In this test 
there is a rapid presentation of visual stimuli to the subject who in turn needs to iden-
tify target items among foils. In particular, CPT measures sustained attention and has 
been extensively studied as a cognitive endophenotype. The NMDA antagonist ketamine 
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impairs performance on CPT in healthy individuals (Umbricht et al. [2000]). 
Purdon et al. reported a study on 15 adult siblings of individuals with schizophrenia 
(high genetic risk group) and 14 healthy volunteers (Purdon et al. [2008]). They found 
that higher levels of Glu and Glx resulted to be associated to the lower score from CPT 
even if not statistically significant (r = 0.32; p = 0.096). 
Two studies from Rusch and Olbrich group have also shown a consistent increase in 
the glutamatergic pool. Left dorsolateral prefrontal cortex but not hippocampal Glu and 
GIn levels have been found increased in 29 patients compared to 31 healthy volunteers 
(Rusch et al. [2008]). Executive functioning was also assessed by the Wisconsin Card Sort-
ing Test (WCST) and its poor performance was associated with increased hippocampal 
Glu concentrations among subjects with schizophrenia, but not among healthy controls. 
Significantly higher Glu concentration in the prefrontal cortex and near-significantly high-
er Glu concentration in the hippocampns were detected in 9 patients with first episode 
schizophrenia when compared to 32 healthy controls (Olbr-ich et al. [2008]). 
Lower Glu levels were observed on mesial prefrontal grey matter when looking at 
changes even caused by genetic factor rather than by disease only (Lutkenhoff et al. 
[2010]). 14 discordant twins for schizophrenia and 1 unaffected co-twin presented sig-
nificant lower values.in Glu compared to the healthy pairs. According to the authors' 
speculation, the fact that almost the same abnormalities were present in the twin pairs 
discordant for schizophrenia might lead to identify a trait marker of the schizophrenia 
risk. That risk marker could become state marker of schizophrenia when it is exacerbated. 
More recently the debate continued both by proving a reduction of Glu concentrations in 
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schizophrenia (Tayoshi et al. [2009]) and by showing that rather than single GIn and Glu 
concentration, only their ratio exhibits a significant reduction (Shirayama et al. [2010]). 
On the other hand, another large body of research is focusing attention on oscillatory 
activity of the brain, and in particular on the theta activity which occurs in the frequen-
cy range of approximately 4-8 Hz. Even though the theta oscillations are particularly 
prominent in the hippocampus of mammals, other sources of theta oscillations can be in 
regions such as ento- and perirhinal cortex, the prefrontal, somatosensory and visual cor-
tex (Raghavachari et at. [2006], Tsujimoto et at. [2006]). Accordingly, theta oscillations 
are involved in memory-related processes: si!!;nificant increases in theta power durin!!; 
encoding of information predict subsequent recall of that information (Sederberg et al. 
[2003]); the theta component over midline frontal regions is enhanced in tasks involving 
both working memory and focused attention (Gundel and Wilson [1992]' Gevins et at. 
[1997]). 
Controls Patients Disease time fit quality Glu GIn Gln/Glu location field strength Ref. 
21 21 21±24 <75% t no ±11% t±24% - L.ACC 4T Theberge et al. [2002] 
21 21 188±107 <75% t J.±11 J. ±24% - L. ACC 4T Theberge et al. [2003] 
16 16 <10 <75% t no ±11 t ±24% - L.ACC 4T Theberge et 01. [2007] 
16 16 <10 <75% t no ±11 t ±24% - ThaI. 4T Theberge et al. [2007] 
16 1 16 <10 <75% t no ±11 J. ±24% - ThaI. 4T Theberge et al. [2007] 
14 10 30.8±43.6 <30% t:j: no ±4% no±5% t ACC 4T Bustillo et al. [2010] 
18 19 87.6±66 <25% t :j: no ±-% no±-% t MPC 3T Shirayama et al. [2010] 
31 29 52.9±47.1 <20% t ±-% t±-% - DLPC 3T Rusch et at. [2008] 
25 30 123.6±104.4 
-% t:I: .j. ±-% no±-% - ACC 3T Tayoshi et al. [2009] 
14 15 -±- <25% ratio no ±15% -±-% - ACC 3T Purdon et at. [2008] 
32 21 63.8±9.4 
-% t:j: t ±9% t±8% - DLPC 3T van Elst et at. [2005a] 
32 21 63.8±9.4 
-% t:I: t ±9% -±8% - Hipp 3T van Elst ct at. [2005a] 
_L--___ 
- -
Table 4.1: Summary of studies at field strength ~ ~ 3T reporting Glu and GIn changes in schizophrenia. Fit Quality indicates the quality control criteria used in the study. t: water 
reference corrected by segmentation; 1: patients after 30 months of medication: :j:: CSF correction applied: 
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Thereafter, the involvement oftheta activity in cognitive and working memory-related 
processes suggests the possibility of its abnormal activity in schizophrenia where impair-
ments of all these domains can occur. Indeed, abnormal evoked theta activity during 
working memory and cognitive control was revealed in a study with 10 patients and 10 
controls (Schmiedt et al. [2005]): while in controls theta activity was particularly promi-
nent over frontal electrodes in the high cognitive control condition, in patients with 
schi7,Ophrenia there was a difficulty to maintain a high cognitive control condition and 
also no increase in evoked theta activity was observed. The well recognized attention 
deficits present in schi7,Ophrenia has also been related to the induced theta reduction in a 
go/no-go task suggesting that low-frequency oscillations are not coordinated effectively 
in schizophrenia during various information processing tasks (Bates et at. [2009]). Thus, 
such finding might open a route to a more complex characterization of variations of the 
neurotransmitters' pools and help to understand those variations in light of the current 
hypothesis of NMDA hypofunction. 
Recently, a positive relationship between hippocampal Glu and theta was established 
in healthy volunteers (Gallinat et at. [2006]). This evidence might suggest glutamater-
gic activity as modulator of oscillatory theta activity. Here, we used a dedicated MRS 
protocol to investigate whether alterations of limbic Glu levels occur in patients with 
early schizophrenia. Secondly, in parallel acquisition of EEG data were used to study 
the interrelation between Glu and theta activity in schizophrenia to investigate whether 
the interrelation seen between hippocampus Glu and theta activity is also visible in the 
Anterior Cingulate Cortex (ACC) and whether that might be altered by NMDA dys-
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function. Our investigation focused also on the idea that the decreased N AA levels in 
schizophrenia are not attributable to neuron loss but can be interpreted as an early effect 
of glutamatergic imbalance. Hence, we also aimed to assess interdependencies between 
prefrontal NAA levels and the disease duration in early stage schizophrenic patients. In 
addition, we aimed to evaluate the further interrelation present between NAA levels and 
Event Related Potentials (ERP) such as P300 and NlOO that are well known to be al-
tered in schizophrenia (Braman et al. [2004]' Gallinat et al. [2002]' Horacek et al. [2006], 
O'Donnell et al. [1995a,b, 2004]). 
4.2 Materials and Methods 
2 The use of human participants in this experiment was approved by the Nottingham 
Local Research Ethics Committee and the R&D department and in accordance with the 
Declaration of Helsinki. All participants provided informed consent. Twenty-seven male 
participants with paranoid subtype of schizophrenia (one left-handed, mean age±SD 
23.36±4.4 years) were recruited from patients within the Nottinghamshire Healthcare 
NHS Trust. Schizophrenia was diagnosed on the basis of a clinical interview, reference to 
case files, and a clinical consensus diagnostic meeting of research psychiatrists according 
to the criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; 
American Psychiatric Association, 2000). Patients with a serious neurological disorder, 
current state of intoxication with substances or current or past substance dependence, 
2The study was performed in collaboration with prof. Liddle's team. The ethics application was 
written by Dr. Amritash Rai. The recruitment was made by Dr. Pavan Mallikarjun and Dr. Lena 
Palaniyappan. The EEG data were acquired and analyzed by Dr. Kathrin Doege 
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another current ICD-lO mental illness diagnosis, personality disorder, or serious visual 
or auditory impairments were excluded from the study. The maximum illness duration 
was 5 years. In order to assess the severity of symptoms and the degree of dysfunction, 
the Signs and Symptoms of Psychotic Illness interview (SSPI; Liddle et al. [2002]) was 
performed and the Global Assessment Functioning (GAF) score from DSM-IV was ob-
tained. A mean total SSPI score of 12.9 (SD = 5.6) indicated that patients were partly 
remitted with only residual symptoms. The mean GAF score was 56.8 (SD = 12.6), which 
denotes mild symptoms or some social or occupational impairments, but generally good 
functioning. All patients were receiving treatment with atypical antipsychotic medication 
[nine olanzapine (5-20 mg per day), four risperidone (1.5-4 mg per day), three clozapine 
(300-375 mg per day), one aripiprazole (10 mg per day)]. 
Twenty-three age-matched healthy males (mean age±SD 28.8±5.4) were recruited as 
controls. Subjects with a history of psychiatric illness in first degree relatives, serious 
neurological disorder, or visual or auditory impairments were excluded from the study. 
The two groups were matched for parental occupational status, determined with the 
National Socio-Economic Classification (NS-EC). EEG was recorded in all subjects prior 
to the MRI session. Only 21 patients and 20 controls accepted to undergo to an MRI 
scan after EEG. 
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4.2.1 MRS acquisition and analysis 
3 A 3T Philips Achieva scanner equipped with a 8 channels SENSE coil was used and 
the protocol included sagittal MPRAGE and two single voxel spectra optimized for Glu 
detection: PRESS TE =80 ms (Schubert et ai. [2004]) (TR=2000ms, 128 averages) lo-
calized on the anterior cingulate cortex (ACC) (voxel size = 30x15x15 mm3 ) and on left 
hippocampus (voxel size = 35x15x15 mm3 ), see figure 4.1. Second order pencil beam 
shimming method on a manually selected volume of interest and water suppression by 
excitation prior to each acquisition were applied as implemented on the Philips plat-
form. Sagittal image reconstruction in both orthogonal planes was used to better localize 
the spectroscopy voxel. Metabolite concentrations were estimated using linear combina-
tion model (LCModel) (Provencher [1993, 2001]). A tailored basis-dataset was used and 
water signal served as internal standard for absolute quantification. The reliability of 
metabolite quantification was judged by the standard deviation of the fitting expressed 
as percentage of estimated concentration (CRLB). Our criterion for accuracy of spectral 
fitting was CRLB<20%. For the correction of the voxel's tissue composition, segmenta-
tion of MPRAGE images was performed using SPM and an in-house Matlab software was 
used to create spectroscopy YOl masks. More details about the software can be found in 
appendix B. The ~ r a y y matter (GM), white matter (WM) and cerebrospinal fluid (CSF) 
contents of each MRS voxcl were determined. Two different corrections were applied: 
water content correction (Swater) and CSF correction (SCSF)' The two corrections were 
based on two different YOls, for water and for ~ A A , , as it results from the chemical 
3The MR data were entirely acquired by myself after being trained as competent MR operator. 
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shift displacement effect heavily occurring in the PRESS sequence. The displacement 
was computed according to the values of the three gradients and the voxel size in the 
three directions. The water content was computed from the water VOl according to the 
standard concentrations in the various tissues4 (ewe'" 0.82 for gray matter, ",0.73 for 
white matter, > 0.98 for CSF). According to McLean et ai. [2000] it is correct to assume 
that the metabolite concentrations in CSF are close to 0 in order to correct for partial 
volume effects due to CSF and to provide metabolite levels per volume of brain tissue. 
This correction has been computed on the basis of the NAA VOl for all metabolites 
and the white and grey matter fraction was used to scale the concentrations. However, 
all concentrations have been considered as measured in arbitrary units as no relaxation 
effect was corrected. 
4.2.2 EEG acquisition and analysis 
5 The experiments were both conducted in quiet location in the Psychiatry Department 
of University of Nottingham by research fellows in the division of Psychiatry. After 
placement of the electrodes, participants were seated in front of a computer monitor. 
Two tasks were used during the EEG recording: the auditory oddball task and the 
go / no go task. 
The auditory oddball task has been very frequently used over the last two decades 
to assess information processing in schizophrenia and we employed an auditory odd-
4The values are expressed as fraction of the pure water concentration: 55mM. 
5This section was not attended by myself and so few details will be given as provided by Dr. Kathrin 
Doege (Doege et al. [2009]). 
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Chemical shift (ppm) 
Figure 4.1 : 1 H-MRS spectrum (PRESS: TR= 2s, NSA=128, TE=80 ms, 2048 sampling 
points, voxel size = 30 x 15 x 15 mm3 ) localized in the Anterior Cingulate Cortex (ACC). 
The major Glu and NAA peaks are displayed on the spectrum. 
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Chemical shift (ppm) 
Figure 4 .2: 1 H-MRS spectrum (PRESS: TR= 2s, NSA= 128, TE=80 ms, 2048 sampling 
points, voxel size = 35 x 15 x 15 mm3 ) localized in the Hippocampus. The major Glu and 
N AA peaks are displayed on the spectrum. 
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ball task because it elicits activation of frontotemporal regions in healthy comparison 
subjects( Opitz et al. [2002]) and it requires top-down organization and integration of au-
ditory information (Opitz et at. [2002]) and patients with schizophrenia exhibit impaired 
task-associated neural function (van der Stelt et at. [2004]). A deep interest were toward 
the control process in schizophrenia. Therefore, since control processes rely on both ex-
ecutive processes and memory retrieval (Verbruggen and Logan [2008]), the Go/NoGo 
paradigm allowed us to assess whether patients with schizophrenia show an associative 
learning deficit that impacts their executive ability to inhibit responses. A current hy-
pothesis states that patients are impaired in learning the stimulus-stop associations and 
that the mapping-switch cost of the reversed mapping in the test phase is decreased. 
Auditory Oddball task: the participants were instructed to fixate their gaze on 
a cross throughout data collection. Two hundred ninety-five stimuli of 50 ms duration 
and 80 dB sound pressure level (SPL) were presented bin aurally to the participants 
through headphones. The stimuli consisted of highpitched target tones (1500 Hz, with 
a probability of 0.15) and low-pitched non-target tones (1000 Hz, with a probability of 
0.85). Stimuli were presented every 2 sec, the order of target and non-target tones being 
randomized. Participants were required to respond to the targets with a button press 
on the keyboard with their right index finger as fast as possible. Prior to recording, the 
participants performed 30 practice trials. 
Go/no-go task: the participants were instructed to fixate the computer monitor on 
which the stimuli were presented. Letter stimuli were presented to participants in white 
font against a black background. Participants were instructed to minimize blinking and 
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not to move during data acquisition periods, except for the finger movement required 
for the behavioural response marked on a computer keyboard. An unequal-probability 
go/no-go task was presented to the partecipants and they were instructed to press button 
with their right index finger as quickly and accurately as possible every time the white X 
(0.80 probability, 240 trials) appeared, and not to press it to the white K (0.20 probability, 
60 trials). With the exception that two Ks were never presented sequentially, the order 
of both letters was random. Reaction time and accuracy were equally stressed. Stimuli 
were presented for 240 ms each, with a randomly varied stimulus onset asynchrony of 
890, 1890, or 2890 ms. To ensure that instructions were understood, each participant 
performed a block of 10 practice trials twice before starting the proper experiment. Scalp 
potentials were recorded from 128 electrodes (Biosemi, Amsterdam, The Netherlands) 
distributed over the entire scalp according to the International Five Percent Electrode 
System for high resolution EEG (Oostenveld and Praamstra [2001]). Eye movements were 
recorded from a bipolar derivation consisting of one electrode placed to the right side of 
the right eye and another below the right eye. All other electrodes were referenced to the 
average electrical potential of the electrodes at the right and left mastoid processes. The 
EEG channels were amplified with a bandpass of 0.1 to 100 Hz, digitized on-line at a 
rate of 256 Hz, and r ~ c o r d e d d on computer hard disk. The cluster of analyzed electrodes 
included C21, C23, Al and A19 which were all on the frontal midline. Evoked potentials 
were obtained for each participant by averaging the segmented data for targets and non-
targets after subtracting pre-stimulus baseline activity within 200 ms before stimulus. 
NlOO amplitude was measured by detecting peaks within 50-150 ms, P300 within 200-500 
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ms after stimulus. 
Time-frequency analysis was performed by convolving the data with a complex Morlet 
wavelet w(t, fo) having a Gaussian shape in time (o-t) and frequency (o-f) domain around 
the centre frequency fo. A wavelet characterized by a constant ratio (fo/ 0-f )=3 was used. 
To analyze evoked activity, the segmented and baseline-corrected EEG data was averaged 
over target and non-target trials for each participant. Then, the wavelet transform was 
applied to the averaged data. For the theta frequency range, post stimulus peak values 
of wavelet coefficients within two different time windows corresponding to the N100 and 
the P300 time window: early evoked theta (0-150 ms) and late evoked theta (200-500 
ms). To obtain induced activity, the wavelet transform was applied to the segmented, 
unaveraged EEG data, from which evoked activity had been removed by subtracting the 
average. Induced activity was determined as the percent change of wavelet coefficients 
in the theta band post stimulus relative to a prestimulus baseline (-300 ms to -200 ms) 
according to the work of Pfurtscheller and da Silva [1999]. In particular, the induced 
theta under consideration was only the one with correct withholdings to the occurrence 
of Ks. 
4.2.3 Statistics . 
The MRS data were tested for normal distribution via Lilliefors test. An unpaired T-test 
W&"l run on the data to assess significant differences; Pearson test was performed to test 
the significance of correlations. To this end the Matlab statistic toolbox wa.'l used. 
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4.3 Results 
4.3.1 EEG results 
The induced theta activity for go/no-go task was significantly reduced in patients vs con-
trols (for electrode C21, mean±SD thetapatients=37.2±30.0 j.lV, thetacontrols=79.4±34.0 
j.lV, p<0.00015; for electrode C23, mean±SD, thetapatients=42.6±37.6 j.lV, thetacontrols 
= 91.3±32.9 j.lV, p<0.00015;) 
The values for ERP, as expected, have been found reduced in patients versus control, 
(for P300 C21 p<0.019 and C23 p<0.014; for N100 C21 p<0.015 and C23 p<O.Oll). The 
mean values across patients and controls are displayed in figure 4.3. 
4.3.2 MRS results 
Most of the data showed a linewidth of 0.030 ppm and the fitting produced accurate 
quantification of all major metabolites (mean NAA CRLB<5% in ACC and <10% in 
hippocampus) including Glu (mean CRLB<12% in ACC and <18% in the hippocampus). 
Glu CRLBs exceeding our threshold value of 20% were excluded from statistics (for 
ACC only one control value was excluded whereas for the hippocampus 8 controls and 9 
patients were excluded.). For Asp CRLBs the threshold values was 22% since few subjects 
had Asp CRLB value of 21 %. The Aspartate values complying with such requirement 
were in total 9 for patients and 14 for controls. Only for the correlations, since one 
patient's EEG data were rejected, the computation was performed on 20 patients. 
N-acetyl-aspartate: NAA was significantly reduced in ACC in patients (mean 
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Figure 4.3: Courtesy of Dr. Kathrin Doege. Grand average of ERPs for controls (solid 
line) and patients (dashed line) for electrodes C2l and C23. The difference between patients 
and controls for NIOO and P300 can be seen around 100 ms and 300 ms respectively (for 
P300 C2l p< 0.019 and C23 p<0.014; for NIOO C2l p<0.015 and C23 p<O.Oll). 
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N AApatients = 29.3±3.9; mean N AAcontrols = 32.1±3.4: 10% reduction, p< 0.02), as shown 
in figure 4.4(a). No hippocampus changes were detected. As shown in figure 4.5, disease 
duration was also found to be strongly negatively correlated to the NAA levels in ACC 
(R=-0.71, p<0.0007), whereas no correlation was seen in the hippocampus NAA levels. 
Furthermore, a moderately positive correlation was observed on a subset of electrodes 
(electrode AI: R=0.35, p<0.03; electrode C23: R= 0.39, p< 0.015; electrode C21: R=O.34, 
p<0.032; electrode A19: R=0.38, p< 0.015 ;) between ACC NAA and the amplitude of 
P300 in the oddball task. Figure 4.6 shows the correlation for the Al electrode. In 
addition, prefrontal NAA revealed negative correlations with NI00 for auditory oddball 
task for the electrodes C21 (R=-0.50; p< 0.025) and C23 (R=-0.52; p< 0.020) (figure 4.7). 
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Figure 4 .4: Anterior Cingulate Cortex NAA decrease (p<O.02)(a) and Aspartate increase 
(b) (p<O.03) in schizophrenic patients compared to controls. 
Glutamate: No change between patients and controls (figure 4.4(a)) was detected 
in ACe Glu as shown in figure 4.4(a) (mean±SD G lupatients = 18.1±2.8; mean±SD 
GIUcontrols = 18. 1±2.9) . In healthy volunteers , a strong positive correlation was found 
between ACC Glu and induced theta (go/no go task) in both electrodes positioned on 
Results 92 
• 
• 
_32 • 
::j 
• ~ 3 0 0 • 
OJ • C 
0 
~ ~ 28 b • c 
.. g 26 
• u 
~ ~ 24 
z • 
22 
20 • 
0 1 2 3 4 5 
Disease Time (year) 
Figure 4.5: Disease duration and Anterior Cingulate Cortex NAA in schizophrenic 
patients (R=-O.71, p< O.OOO7). 
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Figure 4.6: P300 amplitude and prefrontal NAA for patients+controls(R=O.35, p<O.03). 
The 4 electrodes under consideration showed a similar correlations. See text for details. 
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the frontal cortex (C23 electrode: R=O.65 p<O.OO1; C21 electrode: R=O.59 p<O.01). 
No evidence of correlation between hippocampus Glu and theta activity was found in 
patients and controls. In general, hippocampus did not show any statistical differences 
between groups. Also, the no correlation was evident between theta activity and Glu 
levels in the hippocampus. 
Aspartate: Figure 4.4(b) shows a significant 15% increase in Aspartatc of paticnts 
vs controls (AsPcontrols=6.0 ± 1.2 mean A,<;Ppatients=7.3 ± 1.4; p<O.03). 
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task in schizophrenic patients_ The correlation in healthy controls is absent. 
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Figure 4.8: Correlations between anterior Cigulate Cortex Glu levels and induced Theta 
activity for go/no-go task in controls. C23 electrode: R= O.65, p< O.OOl j C21 electrode: 
R=O.59, p< O.Ol. The correlation is lost in schizophrenic patients. 
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4.4 Discussion 
Our findings show no reduction of the Glu levels ill ACC and hippocampus of early 
schizophrenic subjects. This is in line with the studies of Theberye et al. [2002] and 
Theberge et al. [2007] which showed only GIn increase and a stable Glu level. On the 
other hand, NAA levels were reduced in schizophrenia compared to controls and no 
correlation was found between the amount of GM, WM and the ratio of them and 
decreased NAA. Thus, it is likely that the NAA loss is not caused by neuronal loss, as 
it has similarly been pointed out in a previous study on hippocampus (Deicken et al. 
[1999]). This would therefore open route to a different and more complex view of how 
NMDA hypofunction translates into metabolic changes in schizophrenia. Not so recently 
Clark et al. hypothesised the role of NAA as a Glu reservoir (Clark et al. [2006]): they 
stated that a so highly concentrated metabolite could have a key role as a storage of 
another equally highly concentrated metabolite such as Glu. This could explain the 
reason why we did not see any evidence of Glu changes despite the fact that many 
lines of evidences point to an increased glutamatergic activity by showing an increase of 
mRNA expression of the astrocytic Glu transporter (Zelenaia et al. [2000]), elevations of 
a neuronal enzyme (phosphate-activated glutaminase) catalyzing reactions of Glu to GIn 
conversion (Gluck et al. [2002]). It is conceivable that the increased and malfunctioned 
glutamatergic activit.y with altered Glu release in synaptic space will be accompanied 
by a high metabolic activity so that Glu levels are reintegrated by NAA reservoir to 
provide the necessary Glu. Hence, the observed NAA reduction in schizophrenia may 
reflect a morc and more intense request of Glu over timc. In fact, NAA levels in patients 
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show a strong and significant negative correlation with disease time but no correlation 
is present between subject age and NAA levels. The hypothesis of NAA as responsible 
of Glu stability in schizophrenia seems also to be supported by the the link with a well-
defined biomarker: NIOO. In line with another work reporting reduction in the magnetic 
counterpart of NlOO (NIOOm) (80ros et al. [2006]), we observed a NIOO reduction and also 
a correlation with NAA in patients. In fact the NlOO is thought to reflect primary auditory 
functions as well as motivation, alertness and arousal (Potts et al. [1998]). Rather than 
a link between neuronal integrity and brain activity, as 80ros and coworkers speculated, 
a link between neurochemical dysfunction and brain activity can be recognized: there 
are indeed evidences of associations of changes in NI00 with NMDA receptor-mediated 
Glu neurotransmission such that NMDA receptor antagonist reduce NlOO in humans and 
monkeys (Murck et al. [2005], Maxwell et at. [2006]). Hence an increase in Glu need for 
synaptic release in schizophrenia would generate such a deficit in NAA. 
At least in the early stage of schizophrenia NAA could provide the amount of Glu 
required by neuron. Given that idea, we could speculate that in long disease duration 
NAA is no longer able to supply the sufficient Glu; evidences of a reduced Glu levels 
in chronic schizophrenia (Theberge et at. [2003], Tayoshi et at. [2009]) and in discordant 
co-twins (Lutkenhoff et al. [2010]) would support this hypothesis. A further evidence of 
this idea would be relying on the increase in Aspartate found in the present study: that 
indeed could be a final product of a series of reactions which are breaking down NAA 
to convert it to Glu. Likely these reactions would have a product accumulating over the 
time in the brain. To our knowledge, no other study on schizophrenia showed changes in 
Discussion 98 
Aspartate, so that it would be extremely important to take this findings with caution. On 
the other hand, this hypothesis would start interpreting the Glu changes from a different 
perspective. 
Interestingly, correlation of the ACC Glu levels with theta activity has been found, 
partially reproducing the results of a previous study (Gallinat et ai. [2006]) that had 
associated theta activity with Glu levels in the hippocampus of healthy volunteers. No 
correlation was found when investigating the hippocampus NAA and in particular only 
the two frontal electrodes presented such a correlation. 
Furthermore, an explanation of absence of correlation of theta activity and Glu levels 
for oddball task can rely on the fact that go/no-go task theta activity is mostly produced 
frontally (as it can be observed by Loreta analysis) while, by contrast in the oddball 
task, theta has also many posterior sources. Therefore, this would imply that the link is 
strongly local. 
Remarkably, this interrelation between ACC Glu and induced theta activity was lost 
in patients with schizophrenia. Although our findings have to be considered preliminary, 
they provide first evidence that prefrontal glutamatergic activity modulates oscillatory 
theta activity and that this modulation is defunct in patients with schizophrenia. This 
dissociation may explain the cognitive deficits seen in schizophrenia despite unchanged 
Glu pools. An interpretation of this absence of correlation in schizophrenic patients is 
complex and would need more investigation. However, it is conceivable that, concordantly 
with the well known fact that the extracellular and vesicular Glu is only a fraction of the 
total cerebral Glu, the remaining part would take part into the cells' energy metabolism. 
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In addition, it is not clear the amount of Glu visible to spectroscopy both in a general 
case and in the particular case of schizophrenia. In fact, MRS studies have failed to find 
20% of Glu which conversely was biochemically measured with different techniques such 
as high pressure liquid chromatography (Pirttilii et al. [1993], Kauppinen et al. [1994]). 
Thus, it is dubious to what the Glu variations might correspond and more specifically 
whether the vesicular and synaptic Glu might have a predominant part in the changes. 
An interpretation might state that the majority of the Glu that is MRS visible is 
in fact associated with glucose metabolism precluding inference on neurotransmitter ac-
tivity changes between patients and controls and its associations with theta activity. 
Nevertheless, a direct link between cingulate glucose metabolism and theta activity has 
been established in healthy volunteers using FDG-PET (Pizzagalli et al. [2003]). A sim-
ilar profound link between MRS visible Glu and glucose is also evident in a study on 
epilepsy showing how Glu and glucose levels were closely correlated (Pfund et al. [2000]): 
that would strengthen the idea that ACC Glu pool levels predicting induced theta may 
reflect glucose metabolism rather than neurotransmission and then supporting the no-
tion that MRS visible Glu mainly reflects the metabolic pool that is however linked with 
neuronal activity. Furthermore, hypometabolism in the frontal lobes is also considered 
a neurobiological correlate of schizophrenia (Horacek et al. [2006]); that indeed corrob-
orates the hypothesis of a coupled interaction between metabolism and theta activity 
where both are reported to be decreased in schizophrenia. Few limitations needs to be 
stated. First of all, this study failed to obtain an accurate quantification of GIn thus 
reducing a part of information about the Glu released in the synaptic space. We were 
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indeed not able to test the hypothesis that NMDA hypofunction leads to an increase in 
Glu release. Furthermore, our patients were under medication and also the drug-taking 
was heterogeneous across all patients. That is to be considered and taken into account 
as an additional variability on the data since the effect of these drugs on the metabolic 
profile is still not clear. Thc last limitation is our sample size so that our results must be 
taken with caution against over-interpretatioll of the null effects. 
4.5 Conclusion 
Our study reported no variation in Glu levels and a disruption of the link between ACC 
Glu and induced theta activity which is present in healthy subject. The changes in Asp 
levels are to be considered still preliminary and to be further investigated. Regardless of 
Asp changes, a hypothesis of NAA as a reservoir of Glu might explain, at least in the 
early stage of schizophrenia, the reasons for a discrepancy between reduced metabolism in 
schizophrenia versus stable levels of Glu. In addition, we speculated that this relevant Glu 
backup originating from NAA is responsible for the lack of the Glu-theta link in patients. 
Our study failed to detect GIn so that no further investigation was possible to test 
whether this metabolites is also coupled to the oscillatory activity. Future investigations 
would then aim to search evidences of this link since GIn is surely more connected to 
neurotransmission pool. Importantly, patients from this study were intentionally chosen 
not acutely psychotic in order to study the early stage of the disease. On the other hand 
the psychotic state itself is an interesting correlate in schizophrenia, since this is likely to 
• 
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alter the metabolic profile. Therefore, we added a preclinical study on animals allowing 
us to investigate a psychotic state artificially induced by ketamine NMDA antagonists. 
---5 
In vivo neurotransmitter profiling· to characterise the 
effects of social isolation and ketamine-induced 
NMDA antagonism: a rodent study at 7.0 Tesla 
5.1 Introduction 
Ketamine is an NMDA receptor antagonist that, in subanaesthetic administration, is 
known to exacerbate the positive, negative and cognitive symptoms in patients already 
affected by schizophrenia (Lahti et al. [1995a], Lahti et al. [1995bJ, Rowland et al. [2005aJ). 
In healthy subjects it produces a wide variety of temporary behavioural symptoms and 
cognit ive deficits similarly to those observed in schizophrenia (Krystal et al. [1994]). Such 
widely spread dysfunctions involving multiple networked regions of the brain are not ob-
served with all psychotomimetic drugs (Javitt and Zukin [1991]), making ketamine and 
other drugs of this class excellent tools for reproducing a schizophrenic state in an exper-
imental model. Even though it is plausible that the response to ketamine might not be 
identical in all aspects to actual schizophrenia's characteristics, there is agreement that 
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ketamine reproduces important aspects of major symptoms of schizophrenia. Also there 
is a potential benefit in creating a drug-induced state of NMDA receptor hypofunction to 
identify various physiological consequences of NMDA blockade in the brain. Despite that, 
studying ketamine in patients has significant ethical issues and this partially motivates 
its use on animal models instead. In fact, numerous studies have demonstrated the pos-
sibility to recreate some pathophysiological aspects of schizophrenia with animal models 
(Dawe et al. [2009], Fane and Porkess [2008]). Although it is extremely difficult to fully 
reproduce the complete ensemble of symptoms experienced in a schizophrenic condition, 
many models have successfully replicated several schizophrenia-like behaviours. 
The model of juvenile social isolation is known to induce schizophrenia-like behaviour. 
In fact, it seems that this intervention has deleterious effects on neurodevelopment and 
also on adult behavior (Fane and Porkess [2008]). It is still unclear how these changes 
occur, but social isolation in rodents can be used to model environmental and emotional 
deprivation in humans. The main difficulty in modeling a neuropsychiatric condition 
such as schizophrenia in rats is the uncertainty in assessing in rodents the presence of 
complex symptoms typically assessable in humans. However, even though the rodents are 
not able to report any delusions or hallucinations and no behavioural test is able to fully 
evidence this complex disease, an array of tests can be utilised for a more substantial 
result. Rearing of rodents in isolation persistently alters the behaviour and then mimics, 
at least partially, the manifestations observed in schizophrenia. Evidence of differences 
are present as withdrawn social interaction, neophobia, reduced cognitive flexibility and 
dysfunctional sensorimotor gating (Fane and Porkess [2008]). 
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Prepulse inhibition of the acoustic startle reflex (PPI) are used to measure senso-
rimotor stage of cognitive development and it has been shown to be impaired in both 
isolation-reared rats (Cilia et al. [2001, 2005], Geyer et al. [1993]) and schizophrenic 
patients (Kedzior and Martin-Iverson [2007], Ludewig et al. [2003]). Structural neural 
correlates of isolation have been proved to be present as well: a study has also recently 
shown a volume reduction in medial prefrontal cortex (mPFC) (Schubert et al. [2009]). 
Also behavioural alterations were demonstrated to be accompanied by specific alter-
ations in hippocampal a-tubulin isoforms and decreased MAP-2 expression which led 
the authors to conclude that those findings are indicative of an abnormal development 
of synaptic connections and reductions in neuronal cell number which in turn may con-
tribute to the cognitive impairments resulting from isolation rearing in rats (Bianchi 
et al. [2006]). 
Still few studies have looked at the neurochemical changes occurring in this animal 
model as well as with ketamine administration. Recently a study on the effects of ke-
tamine on healthy volunteers has reported an elevation of GIn in the prefrontal cortex 
(Rowland et al. [2005b]). The study was performed on a 4 T scanner and in vivo spec-
tra were acquired f r ~ m m the bilateral anterior cingulate of 10 healthy subjects while they 
received a subanesthetic dose of either placebo or ketamine. An increase was observed 
in GIn between ketamine and placebo whereas no change was detected in Glu. Similar 
findings were obtained by another group on animal model using a different NMDA antag-
onist, phencyclidine (PCP). Gln/Glu ratio showed an increase after PCP injection but 
the total concentration of these two metabolites remained constant (lltis et al. [2009]). 
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Melendez et at. [2004] used micro dialysis techniques to detect changes in the overall 
Glu release in the prefrontal cortex of isolation-reared rats. No significant changes were 
found about Glu release, but a specific decrease was present in the mGluRl and mGluR5 
receptor subunits in the dorsal PFC. The authors concluded that a reduced transmission 
is then conceivable and may result in cognitive deficits. 
In rats, micro dialysis has been also used to report that a subanaesthetic dose of 
ketamine leads to an excessive release of Glu in the prefrontal cortex, as depicted byele-
vated extracellular Glu in the region (Lorrain et at. [2003]). Lorrain et al. also concluded 
that the Glu elevation seen in the medial PFC is as a result of ketamine acting at a site 
outside the mPFC. 
The aim of the present study was then to investigate at ultra high field strength 
both the effects of pure isolation and the effects of only ketamine on healthy animals 
and, ultimately, the effect of ketamine and rearing isolation on the metabolic profile. 
Special interest was given to the neurotransmitter pool, GABA, Glu and GIn, as well 
as their time course during the ketamine injection. Specifically, we aimed, according to 
the current hypothesis, to show a reduction of GABA and an increase in glutamatergic 
activity. We e x p e c t ~ d d those changes to be greater in a psychotic state as it might be 
the state of isolated rats after ketamine injection. Also we wanted to examine the effects 
of isolations on the metabolic profile to see whether that reproduces differences seen in 
humans. 
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5.2 Materials and Methods 
5.2.1 Animals 
IThe study made use of 16 male Lister Hooded rats. MRS data from the anterior cingulate 
cortex (ACe) were only obtained from 13 of the rodents (n=13), whereas data from 
the left hippocampus (LHC) were acquired from the remaining 3 rats. All experiments 
complied with Home Office regulations as detailed in the Animals (Scientific Procedures) 
Act 1986 and were approved by the local Ethical Review Committee. All efforts were 
made to minimize the number of animals used and their suffering. 
The rats were equally and randomly divided into two groups: 'isolates' and 'non-
isolates'. The isolates were reared in isolation from postnatal day (PND) 23-25. They 
had no physical interaction with their littermates, but only auditory and visual contact 
were allowed. The isolation period was 7 weeks. The control group (non-isolates) were 
housed in two groups of four from PND 23-25. Both sets of rats had free access to food 
and water. Temperature was maintained at around 21 DC and humidity at around 60% 
for both groups. The isolates were maintained with minimum handling. 
Prior to scanning rats were assessed in a battery of behavioural tests, each of which has 
translational salience to core behavioural deficits seen in schizophrenic patients. These 
behavioural tests not only have ensured that a robust neurodevelopmental change has 
been produced by the early-life environmental manipulation but also enabled subsequent 
lThe acquisition was done by Dr. M. Prior, ketamine injection and animal preparation performed by 
Dr. M. I. Schubert. Mr Khalid Shah, Bmedsci student, took part in the analysis of the data under my 
co-supervision. 
Materials and Methods 107 
cross-correlation analysis between behavioural, morphological and neurochemical changes 
to be determined in the same animal. More details can be found on Schubert et al. [2009]. 
The rats were anaesthetised using 1.75% isofiurane in a mixture of nitrous oxide and 
oxygen gas in a ratio of 2:1 and then each rat was subcutaneously injected with 25mg/kg 
ketamine and with same amount of saline. In order to balance any potential bias related 
to the sequence of injection, a cross-over model was designed: each animal was randomly 
assigned to a group and the order of injection of ketamine and saline was different for 
two groups. The group with administration of ketamine first was given saline second and 
viceversa (see figure 5.1). 
Anaesthesia 
administration 
Acqulsltton 
started 
Anaesthesia 
administration 
Baseline 
/ 
'\ 
Baseline 
Ketamlne 
(I GROUP OF RATS) 
Saline 
Ketamlne 
Saline (II GROUP OF RATS) 
Figure 5.1: Cross-over saline/ketamine injection. 
A 7 T animal scanner (Avance Biospec 70/30 USR, Bruker System) was used. Spec-
tra were acquired from a 3x2x2 mm3 voxel positioned in the prefrontal cortex/anterior 
cingulated cortex (ACC)(see figure 5.2(a)). The localization was achieved with a Point-
Resolved Spin echo Sequence (PRESS) (TR=5000 ms, TE=8 ms, number of points= 2048 
SW=4006 Hz) . From the acquisition starting point, 24 spectra with 32 averages each were 
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acquired: they were divided in 8 for the baseline, 12 for ketamine and 8 for saline. 
The acquisition structure was conceived to give a reasonable time resolution and to 
allow a dynamic study of the process. Each spectrum was also acquired with VAPOR 
water suppression (see figure 5.2 (b) ). 
5.2.2 Data processing 
Before analyzing the data, the Bruker's filter needed to be compensated. Afterwards, a 
conversion to text file was performed to be able to import them into LCModel and jMRUI 
software packages. The small voxel and consequently high noise in the data precluded 
using the available temporal resolution so that the spectra at different acquisition times 
were averaged to attain a reliable quantification for the set of metabolites of interest. 
The unavailability of unsuppressed water spectra implied that no absolute quantification 
was possible. Total creatine ratio quantification was then used for analysis. 
In order to have a reliable estimation of concentrations, the optimal compromise be-
tween time resolution and SNR was to average every 4 spectra to get 128 averages per 
time point. In order to reduce the line broadening due to the frequency shift among the 
spectra, a Matlab script based on a cross correlation method (see appendix A) automat-
ically realigned the spectra before summing thelll. III case of ketamine injected first, the 
final output was hence structured as: 
• BAS! Baseline (0-10 minutes) 
• BAS2 Baseline (10-20 minutes) 
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• K ETl Ketamine (20-30 minutes) 
• K ET2 Ketamine (30-40 minutes) 
• K ET3 Ketamine (40-50 minutes) 
• SAL l Saline (50-60 minutes) 
• S AL2 Saline (60-70 minutes) 
whereas in case of saline injected first the structure was: 
• BAS'l Baseline (0-10 minutes) 
• BAS2 Baseline (10-20 minutes) 
• SAL l Saline (20-30 minutes) 
• SAL2 Saline (30-40 minutes) 
• K ETl Ketamine (40-50 minutes) 
• K RT2 Ketamine (50-60 minutes) 
• K ET3 Ketamine (60-70 minutes) 
where the total time is deduced from the TRx NSA. Also, by averaging the subgroups, 
an overall effect was investigated which included only 1 baseline, 1 ketamine and 1 saline 
time point. A growing interest on the changes of neurotransmitters' ratio motivated a 
statistical analysis of the effects on their balance. 
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All the quantifications were performed on LCModel software (Provencher [1993, 
2001]) with an appropriate basis dataset. The cut-off CRLB for all metabolites with 
exception for GABA was 20%. All data complied with this requirement so that the total 
number of rats (n=13), with isolates (n=7) and non-isolates (n=6) was included for the 
metabolites comparison. For GABA, since the level of GABA detection was lower after 
ketamine, a less stringent cut-off was chosen for CRLB (28%). An entire dataset from one 
isolated rat was then excluded from the analysis because it did not meet the requirement. 
5.2.3 Statistics 
The concentrations were exported and statistically analysed in SPSS software package. 
All the analysis were then divided into: 
1) Effects of isolation 
2) Effects of ketamine 
3) Combined effects of ketamine and isolation 
An independent-samples t-test was applied to compare the baselines between group-
housed and isolated'rats (1). 
A repeated measures ANOVA was applied to check statistical differences after injec-
tion, when analysing multiple time-resolved points after each injection ((2) and (3)). 
Before applying any of the above tests, all variables were tested for normal distribution 
using the Shapiro-Wilk test. 
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Figure 5.2: Voxellocalization on rat Anterior Cingulate Cortex (ACC) . (a) j Correspondent 
spectrum TE=8 ms, NSA=128. 
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5.3 Results 
No significant differences in the baseline values were observed in the entire visible metabol-
ic pool between isolation-reared and group-housed rats. 
5.3.1 Housing-independent analysis 
Glu and NAA concentrations (see figure 5.3) were found unchanged in both housings dur-
ing the injection t ime course. GIn proved to increase regardless of the housing (p=O.009) 
(see figure 5.3) at the last time point (K ET3); conversely GABA showed a decrease 
straight after t he ketamine injection (K ET1) (see figure 5.3) . 
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Figure 5.3: Time-resolved of metabolic variations after ketamine injection. Glu, GIn, 
GABA and NAA-total creatine ratio are shown. GAB A decreased at the first point after 
ketamine injection (p< O.047); GIn is significantly increased at the last point after ketamine 
injection (p<O.009). 
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The metabolite ratios were also inspected to assess differences after ketamine injec-
tion: 
• Gln/Glu displayed a significant increasing (p=0.014) from baseline to last time 
point (see figure 5.4). 
• significant stepwise reduction in the GAI3A/Gln (see figure 5.4) values from baseline 
to first (p=0.014), second (p=0.014) and third time point (p=O.017), indicating 
that GABA levels fall as soon as the ketamine is administered and continue to go 
down for up to at least 30 minutes post injection. 
• a similar tendency of decreasing is also evident in GABA/Glu, but the data show 
a decrease similarly to the total creatine ration values (p=O.043). No significant 
difference arose from the data when observing a total effect on the entire period of 
32 minutes. 
5.3.2 Group.·housing analysis 
Even in the case of separated analysis, no difference was observed when looking at NAA 
. 
and Glu. Also, GIn showed a significant increase in the last point of ketamine injection 
(K ET3 ) for non-isolated rats (p=O.021), but only a trend of increase for the isolated rats 
which failed to be significant (p=O.108), see figure 5.5. GABA did not show a change 
after the ketamine injection as in housing-independent analysis. A trend of decrease in 
GABA for K ETI (p=O.070) and K ET2 (p=O.078) was detected. In contrast, a significant 
drop was observed exclusively for isolated rats at the last time point (K ET3): in fact, an 
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Figure 5.4: Time-resolved ACC metabolic changes in isolated and group-housed rats in 
response to 25mg/kg ketamine injection. GABA/Glu is significantly decreased at the first 
ketamine point in time (p< O.043) . Gln/ Glu shows a significant increase 32 minutes after 
ketamine injection (p< O.Ol) , GABA/ Gln decreases significantly at the first (p< O.045) and 
also second point (p< O.007). 
opposite tendency (not significant) of GABA increase was suggested in the group-housed 
rats. This was however significantly different from t he first t ime point after the ketamine 
injection (p< O.032) , see figure 5.6. Analysis of GABA-Gln ratio revealed decreased values 
in rats reared in isolation for all three time points (K ET1 : p= O.014; K ET2 : p= O.014; 
K ET3: p= O.017; see. figure 5.7). 
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Figure 5.5: Time-resolved ACC GIn concentrations in isolated and group-housed rats 
in response to 25mg/kg ketamine injection. A significant increase is observable in group-
housed rats (p= O.021) but only a trend of increase is present for isolated rats (p=O.108). 
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Figure 5.6: ' Time-resolved ACC GABA in isolated and group-housed rats in response to 
25mgjkg ketamine injection. GABA shows different trend for group-housed and isolated 
rats: respectively significant decrease (p< O.032) from the baseline point and significant 
increase within ketamine injection points. 
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GABA/Gln 
• Isolates 
• Non-
isolates 
Figure 5.7: Time-resolved ACC GABA-Gln in isolated and group-housed rats in response 
to 25mg/kg ketamine injection. Significant drop in the ratio: K ET1 , p=O.014; K ET2, 
p=O.014; KET3, p=O.017. 
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5.4 Discussion 
In summary, no difference was observed between the group-housed rats reared in a social 
isolation. After ketamine injection ACC NAA and Glu were stable in line with what has 
been found in the study on PCP by Iltis and coworkers (litis et al. [2009]), where Gln/Glu 
ratio, rather than their absolute concentrations, was reduced. Conversely, regardless of 
the group housing, after about 30 minutes from an injection of 25 mg/kg of ketamine 
a significant increase in GIn was observed. Consequently, even the GIn and Glu ratio 
was significantly increased, reproducing the main results of the just cited study. The 
stability of Glu can be interpreted in light of some important considerations about the 
Glu pools. Glu is indeed involved in both a metabolic and neurotransmission pool and 
MRS cannot distinguish between the two (Pirttilii et al. [1993], Kauppinen et al. [1994]). 
In fact, the neurotransmitter Glu is probably packed in vesicles and then likely invisible 
to NMR, whereas Glu in the presynaptic space is quickly removed after its release and 
converted back to GIn. GIn was thus speculated to reflect the glutamatergic synaptic 
activity more appropriately than Glu levels, and, indeed, it has been shown that GIn is a 
good index of the turnover of the synaptic Glu involved in neurotransmission (Rothman 
et al. [2003], Kanamori et al. [2002]). Given that, the increase in concentration of GIn 
might indicate that NMDA blockade leads to a larger amount of Glu release at the 
postsynaptic terminals of the glutamatergic pyramidal neurons. 
Beside that, the elevated levels of GIn might be a further measurement of an increased 
activity which was also observed by studies looking at the BOLD fMRI signal (Littlewood 
et al. [2006a,b]). Such increase is also in line with studies that used MRI perfusion and 
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that reported an increase in hemodynamic response following PCP administration in 
animals (Cozzi et al. [2008]). Additionally, studies using positron emission tomography 
(PET) have shown a frontal lobe activation in rCBF and higher eM Rg1u indicating a 
metabolic hyperfrontality (Holcomb et al. [2001]' Vollenweider et al. [1997]). Evidences 
of a similar effcct 011 humans comc from Rowland et al. (Rowland et al. [2005a]) who 
proved an increase following ketamine administration. 
Compared to the study of Iltis and colleagues (lltis et al. [2009]), an interesting 
significant G ABA decrease was measured in rats reared in isolation but not in group 
housed rats. The study from Iltis et al. had indeed shown a not significant reduction in 
GABA after PCP injection. To our knowledge, this is the first in vivo study characterizing 
the metabolic effect of ketamine on GABA. This also opens a new route of further 
investigation about the GABA's role in schizophrenia. A high-resolution magic spinning 
angle study on postmortem tissues at ultra high field strength (16 T) was able to detect a 
similar decrease in GABA concentration by comparing prefrontal white and grey matter 
of 10 schizophrenia and 10 control individuals (Prabakaran et al. [2004]). According to the 
NMDA hypofunction hypothesis, as a NMDA antagonist, ketamine would cause NMDA 
receptor blockade OR GABAergic interneurons with a consequent decreased inhibitory 
activity from the GABAergic inhibitory interneurons and resulting in a downstream 
hyperglutamatergic state (Moghaddam et al. [1997], Olney and Farber [1995], Olney et ai. 
[1999]). Our study failed to see a significant decrease in GAB A exclusively for isolates at 
the first time point where the housing-independent analysis showed a significant drop for 
all rats. Most likely the reason relies upon the small sample size for the isolates. However, 
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a trend of decrease is observed and that would fit in the hypothesis of decreased inhibitory 
activity from the GABAergic system. In fact, we can speculate that the earlier effect of 
ketamine on the GABA could be interpreted as a cause of the observed GIn increase 
later on. A further evidence is attainable from the GABA and GIn ratio data where it is 
arguable that the second point in time expresses this progressive passage from reduced 
inhibitory activity to high glutamatergic activity. This effect is very profound in rats 
reared in isolation thus supporting the hypothesis that the isolation housing would lead 
the animalf; to be more sllsceptible to the kctamine effects and consequentially to NMDA 
blockade. 
In line with that, the reason of the last time point GABA increase in group housed rats 
could be found in a process which tempts to restore the GABA level back to normal. 
GABA decrease resulted successfully restored in healthy animals, but such a process 
might be no longer effective when a not complete neuru-development takes place, thus 
leading to a longer and more persistent effect over time. These explanations remain 
speculations and caution is needed to avoid over-interpretations of the results. Further 
investigations need to be undertaken to address this effect. 
5.5 Conclusions 
A study on an animal model of schizophrenia was undertaken. The work involved also 
the injection of ketamine to study the psychotic state od the disease. Two interesting 
changes were observed in the study as an effect of ketaminc administration: a Gln increase 
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showing an higher glutamatergic activity; a GABA decrease in isolates giving evidence 
of the more profound effect of ketamine on rats lacking a complete neuro-development. 
Part III 
GABA-optimised sequence and 2D fitting 
procedure 
- 6 
Optimised PRESS sequence for GABA detection 
6.1 Introduction 
Gamma aminobutyric acid (GABA) is the most important inhibitory neurotransmitter 
in the central nervous system and a large number of psychiatric and neurological disor-
ders such as anxiety disorders, epilepsy, schizophrenia and insomnia (Wong et al. [2003]) 
have been associated with GABAergic dysfunction. Proton MR spectroscopy (lH-MRS) 
is the only technique to non-invasively assess cerebral GABA levels and thus characterise 
disease related alterations and the effects of medical treatment. Quantification of intrac-
erebral GABA is however challenging since resonances of GABA overlap with signals of 
other metabolites that are more highly concentrated than GABA with concentrations 
between 1.4 mM and 2 mM (Govindaraju et al. [2000]). Therefore, in vivo spectroscop-
. 
ic determination of GABA mainly relies on elaborated editing sequences that are not 
routinely available on clinical scanners. 
The GABA has 3 main groups of protons, C2 protons at 3.0 ppm, C3 at 1.88 ppm 
and C4 at 2.28 ppm. Around 3.0 ppm, GABA is strongly overlapped by the methyl 
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group of creatine. Fortunately, the absence of J-coupling allows the use of a variety of 
spectroscopic techniques to suppress it. The first technique to detect GABA utilized 
semiselective refocusing pulses to inhibit J modulation of C4 GABA resonance (3.00 
ppm) (Rothman et ai. [1993]). After that, several methods have been implemented mak-
ing use of multiple quantum filtering (Keltner et ai. [1996, 1997], Shen et ai. [1999, 
2002]), two-dimensional spectroscopy (Ke et ai. [2000], Schulte and Boesiger [2006a]) as 
well as numerically GABA optimized inversion pulse for homonuclear editing sequence 
(Hetherington et ai. [1998]). Although tcchniqucs such as multiple quantum filtering or 
spectrally selective pulse provide an estimation of GABA concentration, they fail to de-
tect the entire spectrum. Conversely, two-dimensional spectroscopy methods allow the 
simultaneous detection of the full spectrum and the single GABA. 
In methods making use of two-dimensional spectroscopy, a full spectrum as well as 
single GABA can be detected. Schulte and Boesinger (Schulte and Boesiger [2006a]) 
calculated intra-subject and inter-subject GABA coefficients of variations (CV) respec-
tively of 17% and 22%. Nevertheless, a longer scanning time makes it not ideal for clinical 
applications. 
Among the J-editing methods, a technique embedded in Point Resolved Spectroscopy 
localization (MEGA-PRESS) (Mescher et ai. [1998]) has evolved. MEGA-PRESS is rel-
atively easy to implement compared to other editing techniques widely divulging its use 
for research purposes (Licata et ai. [2009], Edden et ai. [2009], Floyer-Lea et ai. [2006], 
Muthukumaraswamy et ai. [2009]). However, MEGA-PRESS is currently still not avail-
able on commercial scanners. A further drawback is the doubling of the acquisition time 
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compared to a PRESS for the same number of averages. A couple of studies (Bogner 
et at. [2010], Evans et at. [2010]) have also shown MEGA-PRESS CV for long term re-
producibility. Specifically, Bogner and colleagues calculated GABA CV with voxel size of 
25 x 30 x 30 mm3 and 128 averages: they found CV of GABA concentration relative to 
water of 15% and relative to Cre of 13.3%. By doubling the time of acquisition and the 
voxel size, Evans and coworkers computed the MEGA-PRESS CV for GABA obtaining 
9.1 % in the visual cortex and 12% in the sensorimotor regions. 
Our goal then was to obtain a similar quality like MEGA-PRESS by testing whether 
clinically available sequence parameters might allow comparable result in the more re-
stricted time of clinical procedure. 
In order for a standard PRESS to meet the requirement of robustness needed we per-
formed a validation by using simulations and in vitro tests. Furthermore, we assessed in 
vivo short and long-term reproducibility between subjects. In this chapter, the feasibility 
of obtaining reliable GAB A estimation using a clinically available sequence was tested. 
To this end, a simulation based parameter optimisation was performed, followed by in 
vitro and in vivo validation. 
6.2 Theory and Simulations 
Simulations were performed to narrow the choice of sequence parameters for subsequent 
in vitro and in vivo experiments. Simulations were performed using Spinevolution soft-
ware (Veshtort and Griffin [2006]) that was also used to create LCModel (Provencher 
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[1993, 2001]) basis dataset for the in vitro and in vivo analysis. For this study we fo-
cused on GABA C4 (2.28 ppm) and C3 (1.89 ppm) proton resonances: the C3 resonance 
is particularly interesting as it may be resolved from the NAA singlet if linewidths are 
reasonably narrow. Nevertheless, at short TEs, macromolecules and lipids may confound 
the fitting in this ppm range. As a consequence we chose longer TEs to mitigate this oth-
erwisc unavoidable problem. Numerical simulations hcnce covered different TE1s ranging 
from 5 ms to 30 ms (with 2.5 ms step size) for long TEs ranging from 70 ms to 130 ms 
(with 5 ms step size). To emulate a realistic linewidth, 8Hz Gaussian data apodization 
was applied, and then the amplitude of the two peaks (C4 and C3) was colour-coded 
and displayed for the T EdTE matrix (figure 6.1). The two matrices were able to pro-
vide a first overview of the two amplitudes' pattern and allowed to easily recognize the 
maximum amplitude for both peaks. 
Similar simulations were carried out to identify and minimize the amplitude of the N-
acetylaspartate-Glutamate (NAAG) signal. In fact, NAAG C3 protons (1.88 ppm) have 
a multiplet resonating very close to the C3 GABA protons and hence it can affect GABA 
quantification. The N AAG glutamate moiety is not usually included into LCModel basis 
dataset and this might generate an unespected independency between GABA and NAAG 
concentrations (Hofmann et al. [2002]). Conversely, at higher field strengths, NAAG 
glutamate moiety was accounted for (Tkac et al. [2009]). 
Opting for the shortest TEl possible in the PRESS sequence, to minimize the prop-
agation of the multiple coherences, a cross checking of the GABA maximum amplitude 
of both protons and minimum contamination arising from NAAG C3 proton amplitude 
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was performed. Corresponding to TE=105 ms and TE1=15 ms (GABA-PRESS) the am-
plitude of the GABA peak for both protons under consideration was maximum whereas 
the NAAG multiplet total amplitude was very close to the minimum. In addition, NAAG 
multiplet at 1.9 ppm is far more complex than GABA multiplet thus leading to not only 
a small difference of their respective peaks when a line broadening is applied, but also 
to substantial reduction of NAAG visible peak. Figure 6.2(b) shows how, in the case 
of GABA-PRESS, a significant difference arises in the C3 protons amplitudes between 
NAAG and GABA. 
However, the simulations were considered only exploratory, since there was no T2 
decay applied. The second part of the study tried to assess the reproducibility of mea-
surements and to determine possible bias. 
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Figure 6. 1: Peak amplitude in arbitrary units for GABA C3 (1.89 ppm) and C4 (2 .28 
ppm) protons. 8Hz apodization was chosen to emulate realistic spectrum. The matrices 
were used to assess the maximum amplitude for both protons. 
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Figure 6.2: (a)Peak amplitude in arbitrary units for NAAG C3 (1.88 ppm) protons. 8Hz 
apodization was chosen to emulate realistic spectrum. The matrix was used to assess the 
minimum amplitude for the protons under consideration. (b) A simulation of peak difference 
between NAAG and GABA for GABA-PRESS. 
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6.3 Materials and methods 
6.3.1 In vitro experiments 
All phantoms were prepared by making use of compounds from Sigma Aldrich company 
and by diluting them in distilled water in plastic containers. After the dilution, where it 
was necessary, the pH was also adjusted back to 7.2 by adding to the solution NaOH or 
HCI. 
The in vitro experiments made use of 2 phantoms prepared for this study: the first 
phantom containing only GABA (3.28 mM) and the second phantom emulating the in 
vivo concentrations and hence containing NAA, mIns, Glu, GIn, GABA and Lac, with 
the concentration values reported in table 6.1. Spectra (64 averages and TR=4000ms) 
with PRESS TE1=15 ms and TE=105 ms, and PRESS with TEs of 40 ms and 80 ms were 
acquired from human-like phantom, whereas spectra (64 averages and TR=4000ms) with 
TEs ranging from 45 ms to 185 ms stepping by 20 ms were acquired from the phantom 
containing GABA. All the data were collected in blocks of 16 averages and, during the 
processing, they were automatically aligned and averaged. The fitting was performed 
in LCModel both {or human-like phantom spectra and GABA's one. The fitting of pure 
GABA needed an operator input of shift due to the fact that the main metabolites (NAA, 
Glu) were not present in the spectra and LCModel could not determinate the right shift 
to be applied to the spectrum. 
The GABA-NAA ratio values from the fitting were compared to the real GABA-
NAA ratio values for each sequence (PRESS40, PRESS80, PRESS105). The choice of 
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GABA-NAA ratio was made to reduce the effect of calibration among sequences with 
different TEs. Furthermore, NAA values are the least affected by uncertainties in the 
quantification and then N AA is more appropriate as reference. The LCModel coefficients 
for NAA and GABA were corrected for relaxation before the comparison. The amplitudes' 
computation was performed on LCModel both for NAA and GABA. NAA T2 value was 
estimated from its computed amplitudes at 40 ms, 80 ms and 105 ms on the mixed 
phantom. On the other hand , GABA T2 value could not be estimated from the same 
data as the LCModcl fitted amplitudes were not sufficiently reliable. The relaxation 
factor was indeed deducted from the data acquired on the GABA phantom. The first 
and the last TE values (TE= 45 ms and 185 ms respectively) were excluded from the 
exponential fitting because they were visually identified as outliers and also because the 
CRLB was found > 20%. 
Table 6.1: Mixed phantom metabolite 's concentrations used for the in vitro test. 
NAA 10 
Glu 9 
GIn 4 
mIns 6 
GAB A 1.6 
Lac 0.6 
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6.3.2 In vivo experiments 
The in vivo experiments were approved by local Medical school's Ethics Committee and 
all volunteers taking part in the study gave written informed consent. 
A 3T Philips Achieva scanner (software release 2.5.3) equipped with 8 channel phased 
array head coil was used. During all protocols, two of the three sequences used in the 
in vitro experiments were used: a PRESS TE=80ms and TEl =lOms (PRESS80) and 
a PRESS TE=105ms and TEl =15ms (GABA-PRESS); both of them were acquired 
with 25 x 25 x 25mm3 voxel size, NA=128, TR=3000ms. Second order pencil beam 
shimming method on a manually selected volume of interest and water suppression by 
excitation prior to every acquisition were applied as implemented on the Philips platform. 
Unsuppressed water spectra were also acquired prior each acquisition. 
The protocol tested two different short term reproducibility (intrasession scan-rescan 
and scan-rescan with repositioning in between) and long term reproducibility. 
A For the intrasession scan-rescan test 5 subjects were scanned to assess the short term 
coefficients of variations. 5 GABA-PRESS sequences were acquired on 2 different 
regions: 3 of them on the ACC and 2 on precuneus (see figure 6.3). Before assess-
ing scan-rescan variability, these data acquisitions also aimed to determinate the 
influence of NAAG peaks on the GABA quantification. For clarity more details are 
provided in the next section, NAAG inclusion test. 
B For the scan-rescan reproducibility test with repositioning 7 subjects were recruited. 
In two different sessions, separated by 10 minutes, 2 sequences GABA-PRESS and 
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PRESS80 were included into the protocol. In order to completely reproduce the 
variability between scans by including head repositioning, each subject was taken 
out the scanner between the sessions. A voxel was positioned on the ACC. 
C To assess long term variability, 2 more subjects were scanned 3 times within a period 
of 3 weeks with a week apart between each scan. 
D In order to assess robustness and sensitivity of the GABA measurement both within 
subjects and within regions 7 healthy volunteers (mean age ± SD = 22 ± 3 years) 
were scanned by choosing two regions, ACe and precuneus as in (A). 
Figure 6.3: Example of localization in the ACC and in the precuneus. 
Spectra alignment and averaging was made by using j-MRUI whereas simulated spec-
tra manipulations were embedded in an ad hoc Matlab script. All concentrations were 
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estimated by LCModel software. The basis datasets for the processing included the fol-
lowing metabolites: NAA, NAAG, Glu, GIn, GABA, Cho and PCh, Cre and PCr, Lac, 
Ins, Ala, Asp, Glc. For the cases A and C the CV was expressed as the ratio SD/mean. 
In addition, the percentile difference (PD) was computed in the case B. The PD was de-
termined as the absolute variation in concentration between scan 1 and scan 2 divided by 
their average concentration for each metabolite. The CV values and PD were expressed 
as percentage of mean value. 
NAAG inclusion test 
As the simulations highlighted, there is a small inclusion of NAAG in the peak at 1.9 
ppm, which can be misinterpreted as GABA. In order to establish whether this NAAG 
contribution is negligible, a preliminary in vivo test was required prior to the in vivo re-
producibility. Simply incorporating the NAAG spectrum into the LCModel basis-dataset 
does not provide sufficient information about the two contributes originating from GA-
BA and NAAG to the peak at 1.9 ppm because NAA usually obscures the NAAG singlet 
thus making the NAAG fitting unreliable. Consequent.ly, the NAAG multiplet area res-
onating at 1.9 ppm remains uncertain and no negligibility limit can be assessed. For this 
reason, two different data processing approaches were taken into account by using two 
different basis-datasets: 
1) Total NAAG; 
2) Two separate basis spectra respectively for the NAAG singlet (1.9 ppm) and NAAG 
multiplets (Split NAAG). 
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Most of the times NAAG singlet dominates the entire fitting of the NAAG spectrum 
since it is more visible compared to the multiplets. On the other hand, as already stated, 
it is hard to distinguish NAA singlet from NAAG singlet. Our approach relied upon 
the idea that LCModel may manage the two components of NAAG separately and thus 
varying the multiplcts independently from the possible identification of the singlet. That 
is beneficial to have an estimate of the upper limit of the 1.9 ppm NAAG multiplets 
contribution since they are not restricted by successful fitting of the NAAG singlet. 
In order to compute the upper limits and to assess the negligibility of the NAAG 
misinterpretation, the concentration percentage differences have been evaluated. In par-
ticular, the Absolute Difference Ratio (ADR) and the Relative Difference Ratio (RDR) 
have been calculated according to the following formulas: 
(6.1) 
(6.2) 
ADR = 2. I MetsplitNAAG - MetTotalNAAG I 
I MetsplitNAAG + MetTotalNAAG I 
RDR = I MetSplitNAAG - MetTotalNAAG I 
I N AAGmult - N AAGsingl I 
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6.4 Results 
6.4.1 In vitro experiments 
The in vitro experiment itself tested the sequence reliability in comparison to shorter 
echo time sequences by fo cusing on measuring known concentrations in phantoms. The 
spectra acquired on the mixed phantoms and two spectra acquired from the GABA 
phantom are shown in figure 6.4 and 6.5 respectively. 
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Figure 6.4: Three spectra acquired on a mixed phantom. 
Among all the sequences tested, PRESSI05 reported the minimum theoretical stan-
dard deviation (CRLB=2%). The GABA and NAA T2 estimates were respectively equal 
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Figure 6.5: Two out of eight spectra acquired on a phantom containing pure GAB A and 
used to compute T2 · 
to 203 ms and 613 ms. The comparison (see table 6.2)among the sequences resulted in an 
overestimation of 3.6% and 11.9% respectively in the case of PRESSI05 and PRESS80, 
whereas an underestimation of 59% was found for PRESS40. 
Ta ble 6.2: In vitro test results for the mixed phantom: report of GABA detection bias for 
t he 3 tested sequences. 
Phantom GABA-NAA ratio 0.157 0.157 0.157 
estimated concentration 0.155 0. 172 0.0966 
percentage difference 3.6% 11.9% 59.0% 
6.4.2 In vivo experiment s 
lThe results for the NAAG inclusion test are reported before the section of short reproducibility 
(case A) even though the subjects are the same. 
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NAAG inclusion test 
The two basis sets were compared in terms of short term reproducibility coefficient of 
variations for the 5 subjects (case A). Table 6.3 shows a good accordance between the 
two sets for each metabolite with the exception of GIn. In fact, for the GIn case, the split 
NAAG method provides an increased CV value in the reproducibility compared to the 
total NAAG method. 
Table 6.3: Short term reproducibility in terms of CVs for all 5 subjects relating to the two 
different basis-datasets. A good accordance is shown for all metabolites with the exception 
of GIn, which has a bigger CV value for the split NAAG method. 
Total NAAG 
N° 1 13.3 2.2 16.6 0.9 
N°2 10.4 1.3 8.2 1.1 
N°3 16.3 1.3 27.5 1.0 
N°4 7.7 1.4 3.1 2.6 
N°5 8.8 1.6 7.1 1.1 
Average 11.3{3.5) 1.6{0.3) 12.5{9.7) 1.4(0.7) 
Split NAAG 
N°1 11.5 2.3 19.8 0.9 
N°2 14.7 1.0 12.3 1.5 
N°3 12.4 2.1 54.1 0.8 
N°4 8.6 1.4 9.1 2.0 
N°5 12.8 2.4 12.2 1.3 
Average 11.9(2.4) 1.9(0.6) 21.5(18.7) 1.3(0.5) 
The table 6.4 indicates the two percentage changes in concentration depending on 
t he basis-dataset used. The two values in the case of GABA are small: its variation in 
concentration is about 4% of the concentration itself and that is about 2% of the difference 
in quantification between the separate multiplet and singlet basis and the total NAAG 
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basis. 
Table 6.4: Percentage differences between singlet and multiplet fitted concentrations for 
short term reproducibility 
ADR (eq. 6.1) 4.3(4.3) 0.5(0.6) 27.0(16.3) 0.9(0.8) 
RDR (eq. 6.2) 2.6(2.3) 2.0(2.3) 14.8(1.5) 5.5(4.6) 
The analysis of the theoretical correlation matrix computed from Fisher informa-
tion matrix led to the same conclusions: by computing the correlations among the basis 
metabolites in the two different cases under consideration, see figure 6.6, the NAAG mul-
tiplet is very poorly negatively correlated to the GABA spectra. Therefore, that may be 
an additional evidence of the weak dependence between the GABA and NAAG protons 
generating the peak of interest at 1.9 ppm. This means that the NAAG contribution, 
and more importantly the error in the fit , can be considered negligible, despite the fact 
that some of NAAG protons resonate at the same frequencies of some GABA protons. 
Reproducibility 
Figure 6.7 shows an example for the fits for the entire spectrum and the single metabo-
lites' components. No spectra have been excluded from the analysis. 
A For the intrasession scan-rescan test to assess short term reproducibility, the results 
for each subject are shown in the table 6.3. For comparison, a table (see table 6.5) 
reporting the CVs and the CRLB for each subjects is displayed. The mean values 
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for the CVs are in general smaller than the corresponding CRLBs except for NAA. 
The mean values for the 4 metabolites are also reported in the table 6.6. 
B For the scan-rescan reproducibility test with repositioning the CVs are reported in 
the second row of table 6.6. Furthermore, CV of PRESS80 are shown in table 6.7. 
The GABA values exceed the 20% whereas the GIn values are below 10%. 
C For long term reproducibility the results are shown in table 6.6. The CV for GABA 
was 11.9 %. The GABA-PRESS reached a Glu long term reproducibility CV value 
of 6.9% whereas GIn was unreliably measured. 
D On a larger number of subjects the CRLB showed a good fitting in both prefrontal 
cortex and precuneus regions (table 6.8) in good agreement to CVs. Also, the 
obtained mean concentration values for GABA are (a.u. mean±SD) 1.76±0.15 in 
the precuneus and (a.u. mean±SD) 1.73±0.45 in the ACC. 
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Table 6.5: Short term reproducibility in terms of CVs and CRLBs for all 5 subjects for 
GABA PRESS TE= 105 ms. The CVs and the CVs' average are the same as in table 6.3 
and are reported again for comparison purposes. 
CV 
N° 1 13.3 2.2 16.6 0.9 
N°2 10.4 1.3 8.2 1.1 
N°3 16.3 1.3 27.5 1.0 
N°4 7.7 1.4 3.1 2.6 
N°5 8.8 1.6 7.1 1.1 
Average 11.3(3.5) 1.6(0.3) 12.5(9.7) 1.4(0.7) 
CRLB 
N° 1 13.7(2.0) 3.0(0) 14.7(3.0) 1(0) 
N°2 14.0(1.5) 3.0(0) 13.5 (1.0) 1(0) 
N°3 19.8(3.5) 3.0(0) 31.1(15.2) 1(0) 
N°4 14.5(1.0) 3.0(0) 12.5(0.5) 1(0) 
N°5 15.8(1.5) 3.5(0.5) 12.7(1.2) 1(0) 
Average 15.5(2.5) 3.0(0) 16.9(8.0) 1(0) 
Table 6.6: Results for scanning reproducibility for GABA PRESS TE=105 ms. t Coeffi-
cients of variation are displayed ; + indicates the percentage differences and that the short 
reproducibility has been performed with repositioning. 
Shortt 11.3(3.5) 1.6(0.3) 12.5(9.7) 1.4(0.7) 
Short with repo} 11.3(10.9) 3.8(2.3) 2.9(1.5) 
Longt 11.9(5.9) 6.9(3.0) 26.5(2.3) 2.3(0.5) 
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Fisher Matrix correlations 
NAA NAAG Ins Glu Gin GABA 
(a) Total NAAG basis 
Fisher Matrix correlations 
NAAG 
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(b) Split NAAG basis 
Figure 6.6: Fisher theorical correlation values for coupled metabolites for the two basis 
datasets used . GABA is poorly correlated with the NAAG multiplets. 
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Figure 6.7: Example for the fits for the entire spectrum and the single metabolites' 
components. 
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Table 6.7: Results for scanning reproducibility for PRESS TE=80 ms. :j: indicates 
the percentage differences and that the short reproducibility has been performed with 
repositioning. 
Short with repot 20.9(17.1) 5.3(2.3) 9.2(5.0) 2.8(1.7) 
Table 6.8: Mean CRLB values on 10 subjects on the brain regions considered. 
Precuneus ' 15.3(2.6) 3.1 (0.4) 19.4(5.3) 1.4(0.5) 
Prefrontal cortex 14.9(3.2) 3.2(0.4) 13.1(3.0) 1.2(0.4) 
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6.5 Discussion 
The in vitro results showed a good agreement between the known concentration and the 
estimated values. However, only the GABA-NAA ratio was compared among sequences 
rather than the absolute concentration, hence the results on the bias include the errors 
coming from the N AA estimate. Furthermore, the phantom does not contain creatine 
compounds thus making ea."ier to fit the peaks at 3.0 ppm since they are not obscured 
by the Cre singlet. However, the in vitro test aimed indeed to prove an improved accuracy 
by using the GABA-optimised PRESS compared to two other sequences rather than to 
provide an absolute accuracy. 
In light of the discussion in the chapter 3, the comparison between CVs and the 
CRLBs in the case of the short term reproducibility gives evidence of good agreement 
between them (case A). That is also better for the singlet (NAA) than for coupled 
metabolites. 
The bias has been also tested for NAAG inclusion in the GABA fitting. The values 
for ADR and RDR give information about the error on the GABA estimate due to erro-
neously fitted NAAG. In fact, as expected, the estimated NAAG concentrations obtained 
using a split basis set are much higher than those present in literature (Govindaraju et al. 
[2000], Edden et al. [2007]). This means that an optimum fitting and consequently the 
NAAG real concentration in healthy volunteers would not exceed the value obtained with 
split basis set. Hence, the ADR reporting only 4% of variations by changing the basis 
sets could be considered as an upper limit of the error. In addition, focusing on RDR, 
only the 2% of the possible NAAG variability in concentration becomes variability in the 
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GABA concentration thus leading to the conclusion that the error on GABA is small 
even though NAAG is invisible to the fitting. 
The same conclusion can be reached from a different perspective, by considering the 
theoretical correlation values coming from the Fisher matrix. The correlation between 
NAAG multiplet and GABA are low and show no strong dependence. 
The three cases of reproducibility showed a similar mean value for GABA but a 
different variability: the repositioning and the different method of CV computation might 
likely cause the difference in the standard deviations. It is also quite visible that the 
GABA optimized sequence does not perform as well as PRESS80 for GIn quantification. 
The study lacks of a statistical test to compute differences in CVs between the two 
sequences. 
Importantly, the voxel size in our study was smaller (15.6 mL) compared to other 
reliability studies using MEGA PRESS where voxel sizes of 22.5 mL (Bogner et al. [2010]) 
and 27.0 mL (Evans et at. [2010]) were used. The sequence does not provide a sufficiently 
good fitting for GIn, but an robust value for the Glu is attainable: that is not surprising as 
the GIn and Glu do not show two separate peaks at a careful visual inspection. However, 
some limitation of the study needs to be stated: firstly, the brain regions tested are 
commonly areas where the shimming is known to be good and no test was performed 
on other brain areas; the voxel size was set large enough because a smaller voxel could 
not provide sufficient signal to detect GABA; given that, careful acquisition is needed 
to keep the spectrum linewidth under 13Hz and performing a good shimming across the 
large voxel. Interestingly, the NAAG does not affect the the GABA fitting but brings a 
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small error in the case that it is not well resolved and distinct from the NAA. On the 
other hand, the GIn concentration was affected by NAAG thus leading again to conclude 
that this TE is not specifically tailored for GIn. In addition, similarly to what can be 
stated about MEGA-PRESS, the sequence is optimized in healthy volunteers and was 
not tested for robustness on diseases where a decrease in GABA is expected and then its 
concentration might go below the actual detection level of the sequence; conversely, the 
values obtained with the corresponding standard dcviationH provide sufficient information 
about the number of subjects to be included in a study. Also, compared to MEGA-
PRESS, the sequence is surely less affected by macromolecules contamination for two 
reasons: firstly, because of the longer echo time macromolecules' spectrum would be 
deeply reduced; secondly, the fitting procedure enables to keep into account them much 
more efficiently and robustly than spectra-difference-based methods which have to deal 
with more complex acquisition and hence with a less obvious spectra models. In fact, 
for MEGA-PRESS the GABA peak resulting from the difference between spectra with 
inversion pulse on and off is usually fitted by a gaussian function thus leading to erroneous 
inclusion of macromolecules and consequently biasing the results. 
6.6 Conclusions 
An optimised standard spectroscopy sequence was tested through simulations, in vitro 
and in vivo experiments. The method proved to be sufficiently reliable to be used in the 
clinical practice as a tool to assess variations in G ABA concentrations. In the two brain 
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regions observed, the sequence is robust to be compared with the MEGA PRESS. 
Implementation of software-based quantification for 
two-dimensional M R spectroscopy 
7.1 Introduction 
The importance of resolving the entire spectrum of metabolites in a single experiment 
and the chance of attaining a reliable single measurement makes standard proton MR 
spectroscopy a not-fully efficient tool for clinical research. In fact, one-dimensional pro-
ton MR spectroscopy is usually useful for some metabolites generally by exploiting J-
editing methods, multiple quantum filters: they may be extremely precise in detecting 
the m e t a b o l i t ~ ~ target but not similarly efficient when enlarging the spectroscopic range 
of interest. On the other hand, the quantification methods currently used rely on spec-
. 
tral fitting techniques which approach the problem solution by modeling analytically 
spectra or performing spectra simulation. Unfortunately the use of more advanced ac-
quisition methods introduces further complexity to be either modeled or simulated in 
the spectrum, and coping with that is not always feasib le. Beside that, in a ID spec-
trum the enormous complexity of the metabolites' models generates solutions which are 
Introduction 150 
not constantly independent but which have a certain degree of interdependency or more 
specifically correlation. Conversely, in 20 spectroscopy it can be shown that adding a 
further degree of freedom would reduce the correlation within metabolite concentrations 
and would increase the robustness of their quantification (Alexander Fuchs [2009]). 
In general 20 NMR spectroscopy is a powerful and versatile approach which is able 
to provide information regarding connectivity (Aue WP [1976]) and molecular distance 
(Macura S [1980]) and only recently the new and indirect dimensions encoded were indeed 
recognized improving unambiguous identification of resonances in in vivo spectra with 
signal overlap that may arise from line broadening (Slotboom et al. [1998]). In practice, 
the growing interest for the use of 20 NMR spectroscopy led to the optimisation of 
fitting techniques for those spectra. A Matlab software package was shown to be capable 
of discriminating successfully more metabolites by also reducing the correlations arising 
among them (Schulte and Boesiger [2006b]). This approach, similarly to LCModel, makes 
use of two particular fitting techniques such as linear combination of metabolite spectra 
in 20 and VARPRO ('variable protection'). Like LCModel it works in the frequency 
domain and requires of metabolite basis spectra. This keeps the number of parameters 
very low compared to methods using parameterized fits. However, this algorithm was 
not able to compute metabolites' T2 estimates since the T2 parameters were included 
in terms of regularization and then forced to be as close as possible to typical in vivo 
values. Moreover, the algorithm has no mechanism to compensate for distortion and 
produce absolute quantification by internal reference. The values indeed are reported to 
total Creatine ratio and no eddy current distortion correction is applied by using internal 
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reference. 
Also the entire algorithm is mainly based on a well-known method of minimization, 
the so-called gradient descent method. Its convergence is considered to be slow since it is 
only linear and, even though the proximity of the minimum is quickly obtained, it does 
not guarantee to reach the global minimum. In fact, it is well known that the algorithm 
can "zigzag" down valleys, performing many iterations to converge. Other than that, an 
obvious consequence of the algorithm structure is a stronger dependency of the obtained 
solution on the starting point when comparing it to other minimization algorithms. This 
could then result in a slow convergence and in a need of an optimum guess of the seed 
points which is far from being trivial. 
The present work aims to take a further step to improve the 2D fitting quantification 
and create a tool usable in clinical practice. The goal of this implementation is to make 
the software more independent from the optimal starting points, reducing the numbers 
of parameters which are constrained and obtaining water-referenced concentrations. 
Based on these considerations, a C-based software package is aimed to be implemented 
for the processing of 2D spectroscopy data in a reasonable processing time. 
7.2 Methods 
The minimization algorithm distinguishes between liner and non linear parameters. The 
non linear parameters are searched within a non-linear least-squares algorithm. In par-
ticular a Levenberg-Marquardt approach is utilized: such algorithm is considered to have 
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a quadratic convergence which is defined as: 
(7.1) 
This faster convergence is also due to the elimination of the "zigzag" effects when close 
to the minimum. The linear parameters are in turn retrieved through methods such as 
Non Negative Least Square (NNLS). This permits a more robust quantification since no 
seed points of the linear parameters need to be guessed at the beginning of the fitting 
routine, and, in addition, the two classes of parameters remain separate. In general, the 
function to be optimized is: 
(7.2) min IIY - Y(x)11 
xEO 
where II . II is the norm under consideration, Y is the signal to be quantified and 
Y(x) is the model function parameterized by the variables x. By applying a variable 
separation between linear and non-linear equation 7.2 can be rewritten as: 
(7.3) min IIY - ~ ( a ) a l l l
xEn 
In this case, q, (a) is a matrix formed by basis vectors and depending on non linear 
variables, whereas a are the linear parameters which indeed represent the concentrations. 
Similar as for LCModel, a set of either basis vectors or basis metabolites is used: compared 
Methods 153 
to analytical basis functions methods, in which the functions are modeled by Gaussians 
and Lorentzians, this method requires a lower number of parameters and it is more 
reliable when the real spectrum has several overlapped peaks. This is usually the case of 
in vivo spectra where a non analytical approach is far more robust. Typically the basis 
can be either acquired or simulated: the acquisition of metabolite spectra from phantoms 
is typically expensive and time consuming and, beside that, the differences in relaxation 
and in lineshape distortions between phantom and in vivo data can not be completely 
corrected thus reducing the quantification reliahility especially in a .I-PRESS experiment. 
On the contrary, simulations have none of those issues, hut have to deal with effects such 
as chemical shift displacement. 
In this work, simulated basis was chosen and, in particular, all metabolites were 
simulated by Spinevolution (Veshtort and Griffin [2006]) with ideal RF pulses and 1Hz 
linewidth to avoid delta functions which are not realistic. The basis metabolites includ-
ed were: aspartate (Asp), creatine (Cre), phosphocreatine (PCr), gamma-amino butyric 
acid (GABA), glutamine (GIn), glutamate (Glu), myo-inositol (m-Ins), lactate (Lac), N-
acetyl-aspartate (NAA), glycerophosphorylcholine (GPC) and phosphorylcholine (PC). 
Having defined tl and t2 as the proper FID evolution times and a fictitious time (namely 
the TE), each metabolite of basis is described by a complex matrix Yl(tl, t2 ) to which 
phase adjustment, line broadening, etc. are applied. In general, each basis can be written 
like: 
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where cPI is the phase adjustment, (31 the line broadening factor, T ~ ~ the transverse relax-
at ion time and II the frequency shift. The total matrix ~ ( a ) ) is then a multidimensional 
matrix built like: 
(7.5) 
Prior to the fitting, the data are processed to account for reference shift, phasing and 
alignment. Spectra alignment is performed according to the explanation given in ap-
pendix A: in order to minimise the number of necessary parameters, an alignment among 
all the TEs was then required. A single shift parameter for each metabolite and for all 
TEs was chosen. A first and second order phase correction is performed by an automatic 
software based on entropy minimization algorithm (Chen et ai. [2002]). In short, the 
function to be minimized is an entropy function like: 
(7.6) 
where h j is the first derivatives of the signal. For spectra showing low SNR, this automatic 
method would fail.and a manual phase adjustment would be required. The reference 
between basis and actual spectrum is obtained by searching the NAA singlet in the 
range 1.9-2.1 ppm. In the case of tumour spectra a reference can be chosen using a 
different singlet if the NAA signal is not present. 
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7.2.1 Lineshape corrections 
The effect of lineshape distortions in a spectrum could result in wrong prediction and 
estimation of concentrations. In general, those distortions are caused by variations in Bo: 
eddy currents and diffusion would generate magnetic field inhomogeneities with spatial 
and temporal dependence, (x, y, z, t). Consequently, two phenomena contribute to deteri-
orating the quality of the spectrum: firstly a frequency dependent phase shift during the 
signal readout leading to a phase distortion; secondly signal dephasing during echo forma-
tion and data acquisition reducing the SNR. In order to correct these effects, techniques 
of reference deconvolution are applied to preprocess the data. In particular, the QUECC 
(Bartha et al. [2000]) method was used. In detail, the deconvolution is performed in the 
time domain and makes use of the reference signal to perform the correction. The actual 
unsuppressed and suppressed water signals, Swater(t) and Smetabo(t), can be expressed as 
(7.7) 
where the signals labeled as ideal are those modeled i.e. with Lorentzian functions; the 
d(t) is an unknown damping factor which generates visible distortions in experimental 
data. The damping factor can therefore be computed from the unsuppressed water signal 
and can be used for the correction of the actual signal according to 
(7.8) 
sideal 
S ideal - water X S (t) metabo - S (t) metabo 
water 
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Dividing by Swater(t) has the potential risk to divide by zero which would generate 
spikes especially at the end of the FID. To overcome this issue, the approach is also com-
bined with a phase subtraction similarly to Klose's work (Klose U [1990]). Furthermore, 
since this approach was not considered to be consistently robust for removing lineshape 
distortions for all the spectra and since it did not always result in a complete correction, a 
distortion model was embedded into the fitting (Soher and Maudsley [2004]). The model 
states that phase distortions can be simulated by a time-dependent factor like: 
(7.9) f(t) = e- j !9(t) with 
n 
where r(t) is the phase correction factor and {}(t) is the actual time-dependent phase. 
~ n n and T ~ ~ are the amplitude and the decay factor respectively. Two values of T ~ ~ have 
been chosen 13 ms and 100 ms. An ideal implementation of this algorithm would involve 
a number of parameters equal to the number of TEs but this would lead to a very long 
processing time. In order to overcome this issue, a mono-dimensional fitting is performed 
prior to the two-dimensional fitting and therefore the effects of phase distortions are 
separately obtained for each single spectrum. Therefore, the parameter values ~ n n are 
utilized to modify the basis metabolites before starting the second fitting in the two-
dimensional space. 
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7.2.2 Starting points 
The choice of starting points is extremely important in order to obtain a reasonable 
minimum value and, even though guessing them is feasible for some parameters, it may 
be not trivial for others. Generally, the shifts and phases are correctly initialized with 
zero, whereas T; 1 and T2 initialization is achieved by random processes. Particularly, a 
Sobol quasi-random sequence (Sobol 1. M. [1967]) is exploited to randomly extract T; 
and T2 from their characteristic range of values. Either for the T; in the one-dimensional 
or for the T2 in the two-dimensional fitting procedure, a set of 50 values centred on typical 
values is chosen. The fitting computes the function to minimize on 100-200 random sets 
of T2 values (each set is made of T2 values, one for each metabolite), and chooses those 
for which the function has a minimum. 
The random approach aims to maximise the coverage of a multidimensional space 
of parameters avoiding at the same time clusters of points. The use of Sobol sequences 
ensures this property despite the use of a limited number of points. With this method 
it is possible to initialise the fitting with only 100 iterations. Figure 7.1 compares the 
uniformity of the coverage of the space of parameters for two random generator methods, 
uniform and quasi-random. It is evident that the Sobol quasi-random method produces 
a more uniform distribution of points. 
1 Here we define Ti. = ~ ~
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7.2.3 Non Negative Least Squares (NNLS) approach 
Linear parameters can be separated from the actual fitting routine by computing the 
Moore-Penrose pseudoinverse 2 The a values of the equation 7.3 can then be retrieved 
by computing the pseudoinverse of cI>(a), cI>(a)+: 
(7.11) a = YcI>(a)+ 
However, since concentrations have to be positive, and the previous method does not 
guarantee the positivity of the parameters to be determined, the problem to be solved 
becomes a constrained problem like: 
(7.12) min IIY - cI>(a)all 
aEH 
with 
This is a well-known Non Negative Least Squares problem. In order to solve such problem, 
we used an algorithm implemented for the first time by Lawson and Hanson (Lawson 
and Hanson [1995]). It has been proved that the algorithm must converge fully after a 
finite number of iterations and hence it can be considered optimal to be included into 
the function which has to be minimized. For completeness, the method's explanation is 
2The pseudoinverse is defined and unique for all matrices whose entries are real or complex numbers. 
It can be computed using the singular value decomposition. 
(7.10) 
Here M* is the Hermitian transpose of a matrix M. For matrices whose elements are real numbers instead 
of complex numbers, M* = MT. 
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reported in appendix C. 
7.2.4 Overview of the algorithm 
Schematically, the procedure can be subdivided into the following steps, also graphically 
represented in figure 7.2: 
1) Pre-processing involving alignment, phase adjustment, reference deconvolution. 
2) Starting one-dimensional fitting to estimate distortion parameters: 
A Initializing parameters such as shifts, phases and distortions' amplitudes at zero; 
B Running 100 or 200 function computations on random input of T;; values from a 
quasi-random procedure. Choice of the best T;; which provides the least value 
for the function 7.2. 
C Performing the function minimization based on the Levenberg-Marquardt algo-
rithm. 
3) Applying lineshape distortions to the basis datasets. 
4) Starting two-dimensional fitting: 
A Initializing parameters such as shifts and phases at zero; T;; values are initialized 
at the mean values coming from the previous fitting. 
B Running 100 or 200 function computations on random input of T2 values from a 
quasi-random procedure. Choice of the best T2 which provide the least value 
for the function 7.2. 
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C Performing the function minimization based on the Levenberg-Marquardt algo-
rithm. 
5) Water amplitude computation. 
6) Results. 
Uniform Random Scatter 
600 
550 ... 
... 
, ... 
...... 
500 .. .: 
.. '. .. 
450 .: ••• • • 
. .. 
*.- ..... 
,. 
.. . 
... 
... 
... , ."" 
• J. 
.. .. . -: 
.. . ., . 
400 
~ ~ 350 
300 
250 
.. 
.. .. .... .. 
~ ~
.. .. . .. 
.. 
.. .... ! .. 
. . 
".. . . 
.. .. .. .. .: ." 
... 
.... .. .. 
.. : .. : .. 
.. : ... 
.. :. 
.. ,.... ..z: . . . . . .. 
.. " ... 
... 200 : . , ,.. .:: . 
.. . . .. : ".: .. ~ . ' , ,
. .. 
150 •• • • ••• • • • • • 
. . 
-:: .. " ": .. " " . .. 
.... 
.. 
... 
. .. 
1 0 0 L L - - ~ ~ ~ - - ~ - - - - - - ~ ~ ~ - - - - ~ ~
100 200 300 400 500 600 
600 
.. 
550 
500 • ... 
T2 
(a) 
Sobol Quasl-Random Scatter 
.. 
.. . 
. . 
. .. 
: 
... 
. ... "." 
. .. 
. .. 
. .. . . 
450 • ••• • • •• . . 
.. 
." .... . . 
400 
~ ~ 350 .. .. .. 
300 . .. 
250 .. . 
.. 
200 
150 
.. 
100 
100 
. . 
" ........ ,,- ". 
. .. 
.. "" .. . .. 
"." .. " ... 
a. " . 
. " .... 
... 
.. .. " ." 
. . 
.. e.," 
. , 
.. 
200 
. .. 
.. . 
300 
T2 
(b) 
.. 
. .. 
400 
. . 
. . 
.... " .. 
. .. 
500 
.. 
600 
Methods 161 
Figure 7.1: The uniform random sequence vs the Sobol quasi-random sequence used to 
initialize the T2 values. The quasi-random method produces a better uniformity compared 
to the other method. This uniformity increases the chances of guessing the right starting 
values. 
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Figure 7.2: Schematic flow chart representing the steps of the 2D fitting procedure, more 
details are given in the text. The 2D fitting is repeated three times adding new metabolites 
on each loop. 
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7.3 Scanning sequences and materials 
In order to assess the quantification reliability and accuracy of the 2D fitting approach, 
we performed tests on a phantom and on two healthy volunteers. Furthermore, the quan-
tification accuracy needed to be compared with a gold standard such as LcModel in order 
to test also the improvement over the standard ID approach. The comparison and the 
quality control for both approaches was based on the computation of the CRLBs. All 
experiments were performed on a 3T Philips Achieva whole-body scanner, equipped with 
8 channel SENSE coil. Scans were performed on a phantom and on 2 healthy volunteers 
who gave informed consent. A voxel of 25 x 25 x 25 rnrn3 was chosen for all acquisitions. 
A J-PRESS sequence was used with echo times ranging from 32 ms to 212 ms in 
steps of 2 ms. The used parameters for J-PRESS were TR=2.5 s for humans and 4.0 s 
for phantom, 8 averages for each TE, spectral bandwidth of 2 kHz and 2048 sampling 
points. 
A PRESS sequence was used with the following parameters: TE=80 ms, TR=2.5 s, 
128 averages, spectral bandwidth of 2 kHz, 2048 sampling points were also included into 
the protocol. For the in vitro test, a phantom was prepared according to the following 
standard brain metabolites'concentrations: NAA 10 mM, Glu 9 mM, mIns 6 mM, GIn 
4 mM, Lac 0.6 mM, GkBA 1.6 mM. 8 scans (4 J-PRESS and 4 TE=80 ms PRESS) 
with no repositioning among them were performed for validation. In vivo validation was 
performed by analysing the data from 2 healthy volunteers. Both JPRESS and PRESS 
spectra were acquired for cross-validation with LCModel. 
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7.4 Results 
The major fitted components of an in vivo spectrum are displayed in the figure 7.3. 
The comparison between the estimates of the phantom concentrations in LCModel 
and in the two-dimensional fitting are shown ill Table 7.1: the CRLBs and percentage 
standard deviations are reported as well. The results for the in vivo quantifications on 
the two healthy volunteers are described in table 7.2. Values for the percentage standard 
deviation smaller than 10% (except for Lac) have been reached with the 2D fitting 
procedure for in vitro test. The in vivo tests were able to show CRLBs lower than 
LCModel's but no further improvement was attained from the two-dimensional fitting 
compared to LCModel's fitting. 
Table 7.1: Results for in vitro quantification: two and one-dimensional spectra are acquired 
on a phantom 4 times. Inter-scan variability (SD), CRLB and concentrations are displayed 
comparing the values for two-dimensional fitting vs LCModel. 
2D fitting LCModel 
metabolite Real Conc. Conc. CRLB (%) SD (%) Conc. CRLB SD (%) 
NAA 10mM 10.5 0.7±0.2 0.9 10.5 1.1±0.2 1.1 
Glu 9mM 9.5 4.7±0.5 1.2 6.5 6.0±0.0 1.2 
GIn 4mM 3.4 6.8±1.7 7.3 3.0 10.0±0.9 9.3 
mIns 6mM 5.7 2.9±1.3 3.1 4.2 8.0±1.6 3.3 
GABA 1.6 mM 1.8 10.2±1.4 9.1 1.5 14.0±1.6 11.4 
Lac O.6mM 1.6 21.0±3.7 16.3 0.6 35.2±7.2 19.4 
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Figure 7.3: Selected metabolite spectra as fitted to an healthy volunteer spectrum. 
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Table 7.2: Results for in vivo quantification: two and one-dimensional spectra acquired 
on the prefrontal cortex of 2 healthy subjects. The table shows the concentrations and the 
Cramer Rao Lower Bound (CRLB) computed by LcModel and by 2D fitting. Besides, T2 in 
ms are displayed. t T2 values and the concentrations are computed on the 3.03 ppm peak. 
2D fitting LeModei 
volunteer metabolite Cone. CRLB T2 (ms) Cone. CRLB 
1 NAA 11.4 0.5% 284 12.9 2% 
Giu 7.4 5.1% 183 7.8 6% 
GIn 1.8 9.3% 226 2.0 12% 
mIns 3.9 7% 178 4.6 6% 
GABA 1.3 15.3% 132 1.1 24% 
Asp 1.6 13.0% 133 2.4 12% 
Cre+PCrt 13.7 1.5% 161 14.2 3% 
GPC+PCh 1.6 1.5% 276 1.9 3% 
Lae - - - - -
2 NAA 12.0 1.0% 289 13.2 2% 
Glu 7.1 6.0% 179 7.6 6% 
GIn 1.8 10.4% 249 2.1 12% 
mIns 4.0 7.5% 192 4.2 6% 
GABA 1.1 16.9% 156 1.0 25% 
Asp 1.8 14.1% 123 2.2 12% 
Cre+PCr 10.2 1.2% 163 10.1 3% 
GPC+PCh 1.5 2.0% 287 1.6 3% 
Lae - - - - -
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7.5 Discussion 
A good accuracy was reached with the 2D fitting procedure for in vitro and in vivo 
applications. Such accuracy was tested on a phantom and compared to LCModel's. The 
comparison was performed on the CRLB, inter-scan variability and concentrations (the 
last two only for in vitro data) for both quantifications. Absolute values of the inter scan 
variability on 4 measurements are very low, since no repositioning was made among each 
scan, but, interestingly, they were smaller in the 2D fitting compared to LCModel's. In 
addition, concentration estimates have been shown to reproduce more accurately real 
values present in vitro. These estimates do not have concentration units, but are provid-
ed in arbitrary unit. Nevertheless, the gain in accuracy is interpretable also as an effect 
of the duplex correction on the T2 , for metabolites and water, which is not implicitly 
applied in ID. Reduced spectral overlap must be considered a further reason for that 
improvement. Looking at CRLBs, it is conceivable that ameliorated separation among 
peaks has an effect on their theoretical correlations which, in turn, have repercussions 
on CRLB. In the in vivo data most of the metabolites are found to have smaller theoret-
ical standard deviations compared to LCModel: importantly, three coupled metabolites 
appeared to have an important improvement, especially for GABA, which has a value 
below 20%. On the other hand, Aspartate and Myo-Inositol have shown estimates slight-
ly larger than the one-dimensional counterpart. Probably, the lack of terms that include 
macromolecules and lipids might confound the fitting and produce a worse quantification. 
Also, no improvement was observed in Lactate quantification and similarly to LCModel 
an unreliable fitting is obtained. The reasons for that depend Hot only on the absence of 
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terms including the baseline, but also on the strong effect that chemical shift displace-
ment at 3T has on the Lactate spectrum, which is well described in literature (Edden 
et ai. [2006]). The T2 estimates for some of the metabolites are in agreement with what is 
available in literature at 3T: comparison can be done among singlets such as NAA, Cho 
and Cre (Traber et ai. [2004]' Miynar'ik et ai. [2001]) and for Glu (Choi et ai. [2006]). 
Of particular importance is the Glu estimate when compared to the value of a further 
estimate at 3T (Choi et al. [2006]). 
An important subroutine, NNLS, is used to separate linear and non-linear variables 
and to have constraints on the concentrations in order to have them positive. 
In comparison, ProFit (Schulte and Boesiger [2006b]) builds functions which compute 
the concentrations and which depend on the non-linear variables. Such functions are 
then constrained to be positive by applying techniques such as Lagrange multipliers: in 
particular, the method tries to avoid values of the non-linear variables that make the 
concentrations negative. In other words, the minimization algorithm plays with two sets 
of constraints; those which are based on a range of values set in real-terms, and those 
which are based on range of values set in abstract-terms and created only to obtain 
positive concentrations. Therefore, the software might reduce the parameters' space too 
much and it might be the case that the found minimum is not the real minimum. 
The NNLS algorithm overcomes this issue and constrains the concentrations as values 
rather than as functions. No further constraint is set for parameters different from the 
concentrations. The second subroutine, the quasi-random initialization, implements the 
need of having a feasible starting point for strongly non-linear parameters which are 
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practically difficult to initialize. This avoids to introduce regularizors into the fitting 
and guess typical values which are mainly known. The last subroutine, the ID fitting 
prior to the main routine, is useful to have lineshape corrections among different TEs 
and to permit a reasonable starting point of linewidths. Furthermore, the basis-dataset 
is simulated with ideal pulses and no chemical shift displacement effect is introduced: 
some metabolites such as lactate do not have a good accordance through all TEs. An 
important and additional feature to be added is including lipids and macromolecules 
into the fitting similarly to what another software package docs (Tarquin, Wilson et al. 
[2010]) by including B-spline functions modeling the baseline into NNLS algorithm to 
retrieve the linear factors. Typical running times are around 12 minutes due mainly to 
Monte Carlo-like search for minima. As the processing time has an enormous importance 
in the clinical practice, further improvements of the method here exposed would aim to 
. decrease the processing time further to meet more stringing requirements. 
Since the initialization algorithm is based on random processes, it might provide 
different starting points for each run. Its robustness and the stability remain to be in-
vestigated. In fact, Monte Carlo-like algorithms are extremely powerful for a global op-
timization but might have the just cited drawback. Consequently, this issue needs to be 
tested and appropriately addressed. A further consideration must be made about the 
lower values of the CRLBs compared to LCModel. Like Profit, these small values might 
be due to the absence of baseline rather than a optimum fitting. In fact, the baseline was 
found to be correlated to many metabolites thus increasing the values of the theoreti-
cal standard deviation (Ratiney et al. [2004, 2005]). It is also true that the correlations 
Conclusions 172 
among metabolites are reduced (Alexander Fuchs [2009]) and, as consequence of these 
two considerations, a clear interpretation is not possible. After having included a term 
taking into account the baseline, additional studies will be necessary to test whether the 
baseline has a so important influence on CRLBs for two-dimensional fitting. 
7.6 Conclusions 
A software package was implemented to accurately fit spectra acquired with J-PRESS 
sequence. The algorithm relies upon three main subroutines which make it different from 
another similar software package (Schulte and Boesiger [2006b]) and lead it to be robust 
enough to estimate T2 without needing to constrain and force them to typical values. 
- - ~ - - 8 8
Conclusions and future work 
My PhD work has been mainly focused on the optimization and applications on schizophre-
nia and animal model of schizophrenia of Magnetic Resonance Spectroscopy in vivo. 
Three interesting and original findings have been reached in this work regarding its trans-
lational part. Increased Aspartate level in schizophrenia patients compared to controls 
thus showing that the hypothesized high glutamatergic activity is visible via a metabo-
lite coupled to Glutamate and belonging to an important shuttle, the Aspartate-Malate 
shuttle. The correlation between Glutamate concentrations and induced theta activity 
present in healthy volunteers is dissociated in Schizophrenic patients. In addition, the 
study on animal model of schizophrenia showed a selective GABA decrease only in iso-
lates rats. A relevant aspect to be studied in the future will be searching confirmations 
of increased aspartate either with a new aspartate optimized protocol or by moving to 
higher field . A short TE sequence on 7T platform would strengthen the reliability of 
the detected concentrations and would provide the important information coming from 
GABA. GABA in schizophrenia is indeed a still unexplored territory and it would be of 
extreme interest using the sequence optimized for GABA to be able to detect this im-
174 
portant metabolite. Reliable Aspartate measurement would also help to study another 
important topic in schizophrenia such as D-Aspartate which is nowadays becoming very 
crucial topic in schizophrenia. 
Grounded on the same concept as used for GABA optimized sequence, simulations 
would be performed to find out potential parameters which would permit to obtain a 
reliable quantification of Glutathione and Taurine. 
The great potential of the 2D approach needs to he confirmed increasing the number 
of spectra such that accuracy and comparison with LcModel might be better tested. Also, 
features such as automatic alignment, spectra referencing, which now work as separate 
pieces of software, will need to be incorporated into the main 2D fitting code. Interest-
ingly, we will adapt this software for quantification of diffusion weighted spectroscopy 
where the echo time variation in the fitting will be replaced by the b value. 
----f2L 
Implementation of Matlab-based code for automatic 
spectra realignment 
During acquisition, the increase in the temperature of the system leads to a natural 
drift of the main magnetic field Eo and consequently of the frequency offset woo There 
is an algorithm on the 3T Philips Achieva platform which is able, while acquiring the 
. unsuppressed water , to st abilize this drift, but it is not always opt imal and requires 
extra scanning time. Unless unsuppressed water is needed, that might be skipped. A 
consequence of the drift is a smearing out of the peak once the whole acquisition is 
averaged. Some of the studies described here used dynamic scanning for the acquisit ion 
and offline aligning was performed to reduce such line broadening effect. 
The code is written in Matlab and requires only a user input of the target (i.e. NAA 
peak) to which all spectra will be aligned. In particular, the edges of one singlet. The 
" 
aligning method relies upon the cross correlation theory of two different signals. The 
cross-correlation is similar in nature to the convolution of two functions. Whereas con-
volution involves reversing a signal, shifting it and then mult iplying by another signal, 
correlation only implies shift ing it and multiplying without reversing the signal. There-
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fore, the cross-correlation is a measure of similarity and hence the proximity of alignment 
of two signals as a function of a time-lag. For two continuous signals, S (t) and Z (t) the 
cross correlation is defined as: 
(A.I) 
which in a discrete space becomes: 
(A.2) Q(t) def 1 N-Iml 
N-I-Iml 
L S*(n) * Z(n + 1m!) 
n=O 
As the convolution, the cross correlation is extremely expensive in term of processing 
time and this is prohibitive when a large data set needs to processed. For this reason, a 
different approach is usually exploited. The propriety of Fourier 'fransforrn can be useful 
for such a goal. Defining Xcn the Fourier 'fransform of XU) as follows 
(A.3) r+
oo 
X(J) = ~ ( X ( t ) ) ) = .1-00 X(t) e-21fitJ dx, 
it is easy to prove that the A.I is a simple product in the reciprocal space: 
(A.4) g(J) = ~ ( Q ( t ) ) ) = S(J) * Z(J) 
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providing the cross correlation function by performing the inverse Fourier Transform: 
(A.5) 
The algorithm then performs few steps in order to align the spectra. The real and 
imaginary part of the FID signal are imported as text files. Since the algorithm is based 
on cross correlation, it relies upon the shift in the number of points of two signals rather 
than their frequency shift. To this end, as you can see in figure A.I, three more steps are 
undertaken: 
• The FIDs are zero filled in order to result in 32K sample points. This huge number 
is necessary to obtain a more precise and fine frequency shift in the following step. 
• The 32K FID signal is Fourier transformed. 
• Operator input of the two extremes of a singlet: nleJt and nright. 
The number of shifting points is therefore computed by calculating the maximum of 
the cross correlation function of the target signal versus the signal to be aligned between 
nleJt and nright. This discrete output hshiJt describing the discrepancy in number of points 
between the two signal is reported into the time domain by: 
(A.6) 
\. 
Importing FIDs 
form text files 
Max 4098 points 
Dot, too 00;5V/ \ Dot' ok 
Gaussian 
apodization 
Applying shifting 
in the time 
domain 
, - - - - - - - - - - - - - ~ ~
Zero filling up to 
32 k number of 
points 
Computing cross 
correlation 
function C;(srSt ) 
and h,hift=max(c;) 
FFT and real part 
selection : 
reference sr and 
target St 
Selecting a singlet 
on the reference 
signal sr 
Figure A.l: The flow chart reproduces the steps made by the algorithm. 
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Figure A.2: Example of 10 spectra before and after performing the alignment. 
Noisy data are difficult to align, therefore the data are apodized to partially remove 
the noise and make the cross correlation computation more robust. An example of the 
software performance on 10 spectra is shown in figure A.2. 
Matlab-based code for automatic water content and 
partial volume corrections 
As described in the quantification methods, it is of vital importance to get a reliable 
reference to scale the metabolites' concentrations and attain absolute concentrations. 
Among different scaling methods, the internal water reference was used as standard 
method for all studies. In order to compute the amount of water contained in the voxel, 
the spectroscopy voxel has to be positioned on the image. The following description 
explains how the code works and the outputs. 
The software was coded in Matlab: DICOMs are taken as input files and binary mask 
in Analyze format are saved as output. A text file with the voxel vertices' coordinates 
in the image frame system is also saved. The image geometrical parameters and the 
spectroscopy voxel in the scanner coordinate system (see f i g ~ r e e B.1) are then read from 
the DICOM header: 
1) pixel size; 
2) off centre values indicating the centre of the entire image stacks: 
(a) Anterior-Posterior (AP) from the tag Private 2005 1078; 
(b) Right-Left (RL) from the tag Private 2005 1079; 
(c) Foot-Head (FH) from the tag Private 2005 107a; 
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3) The Euler angles of the unit vector 1, y, Q (see figures B.2 and B.3) in an image, 
imported from the ImageOrientationPatient tag; 
4) The coordinates of the upper left pixel (see figure B.2) for each slice, imported from 
the ImagePositionPatient tag; 
5) N: Number of Slices from the tag NumberOfFrames; 
6) Width and Height, respectively number of rows and columns from the similarly 
named tags; 
7) Main frequency value from the TransmitterFrequency. 
Similarly, the voxel geometrical information was imported from the Dicom files. A 
feature to import the geometrical information from the spar file is available and in that 
case the AP and RL voxel coordinates need to be flipped as the coordinate system is 
inverted compared ~ o o the DIeOM file. Therefore, the geometrical data are the following: 
1) the voxel size sizeap sizecc sizelr respectively from the tags Private 2005 1057, 
Private 2005 1058, Private 2005 1059; 
2) offcentre values offap offcc offlr indicating the voxel centre respectively from the 
tags Private 2005 105a, Private 2005 105b, Private 2005 105c; 
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Patient coordinate system 
RL-AP-FH 
FH 
AP 
Figure B.1: The right handed coordinate system in the magnet: the magnet isocentre is 
determined as intersection of the three orthogonal axis. 
Figure B.2: Pixel size and offset value for each slice were utilized to compute the 
geometrical intersections between voxel and image planes. 
>1 
Intersection coordinates on 
image slice plane: ( Xn Yn ) 
D 
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Figure B .3: The square edges were obtained from the intersection between voxel segments 
and image planes. The image versors were exploited to determinate image stack orientation. 
3) the angulation values by which the voxel is rotated: angleap anglecc anglelr respec-
tively from the tags Private 2005 1054, Private 2005 1055, Private 2005 1056. 
The voxel is then built as a set of line equations defining the edges of the voxel, see 
figure B.4. 
If we define the versors in the scanner coordinate system as follows: 
1 0 0 
(B.1) ~ ~ --:- ~ ~ X3 = k= Xl = Z = 0 X2 =J = 1 0 
0 0 1 
cc 
ap 
Lines defining 
the voxoi's 
/ / / ~ ~ ' '
r--+--------2 //1 
i, 
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Figure B.4: The segments describing the voxel edges were used to compute the 
intersections with image planes. 
and the position coordinates: 
(B.2) ~ ~ = [±Sizeap/2 ±sizelr/2 ±sizecc/2 ] 
each line can be described through the coordinates of a point on the line fu, its 
direction Xl and its extreme points !q,- fu+: 
3 
(B.3) 121 = L ~ ~ . xm - ~ ~ . Xl 
n=l 
In the same way the image planes were constructed by defining the versor perpendicular 
to the plane g and the coordinates of a point on each plane Bn=(APo, RLo, F HO)n 
with n=1,2, ... N. Before performing the intersection between voxel and planes, the voxel 
needed to be rotated and translated to adjust the voxel position in a single reference 
system, the one from the image. The rotation matrices were defined as: 
(B.4) 
(B.5) 
(B.6) 
1 o o 
Rap = 0 cos( angleap) - sin( angleap) 
o sin( angleap) cos( angleap) 
cos( anglelr) 0 sin( anglelr) 
Rlr = o 1 o 
- sin( anglelr) 0 cos( anglelr) 
cos( anglecc) - sin( anglecc) 0 
Rcc = sin( anglecc) cos( anglecc) 0 
o o 1 
where the total rotation matrix is the product of the previous matrices: 
(B.7) 
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whereas the translation vector is given by: 
offi:r 
(B.8) offap 
offcc 
The new voxel parameters !il,:?l, !Lt-, !Lt+ will then be 
(B.9) !il = RQI + T; !it = R!J.z- + T; 
The intersections between the planes and the voxel segment lines are then computed. 
This implies the knowledge of the cross-section of the voxel for each slice and its respec-
tive coordinates. The method of the intersection is not very fast but the voxel ROI was 
primarily meant to be used in Jim software before being used in Analyze format. The 
creation of binary masks from the coordinates was performed by poly2mask Matlab func-
tion. Since the use of high field strength combined with PRESS localization determines 
a quite strong chemical shift displacement, the software computes also binary masks for 
different metabolites and consequently different chemical shift according to the formula 
2.42. Given NAA as reference, the metabolites taken into account were Ins (1.606 ppm!), 
water (2.692 ppm), and Cho (1.171 pm). An example of the displacement computed is 
in figurc B.5. 
Corrections for water content and partial volume effect involved the use of bina-
IThe ppm values are calculated by setting NAA singlet peak as zero. 
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Figure B.5: An example of the localization and the voxel size used for the study regarding 
schizophrenia disease (see chapter 4). The white box represents NAA localization and the 
black one represents the water. 
ry masks and the segmentation of an MPRAGE acquired to this end. In general the 
correction factor for water content in molar units is deduced from the following formula: 
(B.lO) Cwater = (WM x 0.73 + GM x 0.82 + CSF x 0.98) * 55M 
where WM, GM and CSF are respectively the percentage in the voxel of white matter, 
grey matter and cerebrospinal fluid. The voxel under consideration is the one correspond-
ing to water chemical shift . Conversely, partial volume effect is corrected by the AA 
chemical shift voxel and by determining the fraction of WM and GM in that voxel. 
--c 
Non Negative least Squares (NNlS) algorithm 
The NNLS (Lawson and Hanson [1995]) algorithm looks for a vector a and its dual 
vector 7] that satisfy the Kuhn-Thcker conditions for Problem NNLS. The input data of 
the algorithm are the integers m and n, the m x n matrix P, and the m-vector Y. The 
working space used consists of two n-vectors 7] and f3 and two subsets P and L of the 
index set 1, 2, ... , n. The components of the current vector Q with indices from the 
set L are zero. The components with indices from the set P can take nonzero values. In 
case this component is nonpositive, then the algorithm will either change its value to a 
positive one or set it to zero and move its index from P to 1. On termination, the vector 
x contains the solution of Problem NNLS, whereas 7] contains the dual vector. 
In detail, the flow will appear as follows: 
1) Starting point: P=0 , L=l, 2, ... , n and a =0; 
2) Compute the vector 7]=4>T(y - ~ ( a ) o : ) ) with the current value of a; 
3) If L=0 or 77j ~ ~ 0 V j E L, then go to step 13; 
4) Find an index 1 E L such that 7]l=maxjEL{7]j}; 
5) Move the index I from L to P; 
(
column j of <I» , 
6) Define the m x n matrix <I» p = 
0, 
7) Compute the (3 as a normal least squares problem: 
(C.1) min IIY - ~ p , 8 1 1 1
8) If (3j > 0 V j E P, then set cx=(3 and go to Step 2; 
9) Find an index q E P such that: 
if j E P 
if j E L 
(C.2) CX cx· q ,q = ~ i n n { J f3 I f3j ~ ~ O} 
cxq - fJq JEL CXj - j 
10) Set 
(C.3) 
11) Redefine cx = CX+A((3 - cx) 
12) Move all indices j "E P where CXj = 0 from P to 1. Go to the Step 8; 
13) Terminate the process. 
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